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Zusammenfasssung  
Reichel, Valeska, Apothekerin, Tag der mündlichen Prüfung: 13.02.06 
Molekulare und funktionelle Charakterisierung von Transportproteinen für Organische 
Anionen 
Referent: Prof. Dr. Gert Fricker, Koreferent : Prof. Dr. Ulrich Hilgenfeldt 
Die Blut-Cerebrospinalflüssigkeit (CSF)-Schranke (BCSFS), wird von den Choroid Plexūs 
(CP) gebildet und stellt zusammen mit der Blut-Hirn-Schranke eine wichtige Barriere 
zwischen Blut und Gehirn dar. Da die BCSFS nur für kleine, lipidlösliche und ungeladene 
Moleküle durchlässig ist, ist es von besonderem Interesse, aktive Transportprozesse für 
geladene Substanzen in diesem Gewebe zu untersuchen, da viele ZNS-Wirkstoffe und 
Wirkstoffkandidaten Substrate aktiver Transportproproteine sind. Transportprozesse im CP 
ähneln denen im proximalen Tubulus der Niere. Deshalb wurden vergleichende Experimente 
mit verschiedenen Modell-Anionen mit isoliertem proximalen Nierentubulus des Killifisch 
und mit CP von Ratte und Dornhai durchgeführt. 
• Zunächst wurde der Transport des fluoreszierenden cAMP-Analogons fluo-cAMP 
untersucht: Inhibitorstudien legen den Transport von fluo-cAMP durch die Exportproteine 
Mrp2 und Mrp4 nahe. Im Gegensatz zum Transport des Mrp2-Substrates Fluorescein-
Methotrexat (FL-MTX) wird der Transport in der Niere nicht durch die Proteinkinasen A 
(PK) A und C (PKC) reguliert. Zur besseren Charakterisierung der kinetischen Parameter 
wurde der Transport von fluo-cAMP in Membranvesikeln aus MRP2 bzw. MRP4 
überexprimierenden Zellen untersucht. Beide MRPs transportieren fluo-cAMP mit gleich 
hoher Affinität. Anders als in der Niere scheint Mrp4 im CP nicht am Transport von fluo-
cAMP beteiligt zu sein, allerdings geben Inhibitionsexperimente mit konkurrierenden 
selektiven Substraten Hinweise für eine Beteiligung von Mrp1. Die Regulation des 
Transportes von fluo-cAMP im Ratten-CP erfolgt nicht über PKA, PKC oder die Mitogen-
aktivierte PK (MAPK). 
• Der Transport von Texas Red (TR) und FL-MTX wurde im CP der Ratte und des Dornhais 
untersucht. TR wird durch Ratten-CPs in einem zweistufigen Prozess transportiert, der 
Metabolismus-getrieben, Na+-abhängig, potentialunabhängig und auch unabhängig von 
Mrp1, Mrp2 und Mrp4 ist. Im Hai ist der Transport von TR Na+-unabhängig, wobei die 
Aufnahme über ein Oat-Protein zu erfolgen scheint, während der basolaterale Efflux 
mutmasslich über das Oatp2-Protein und Mrp1 erfolgt. 
• Die apikale Aufnahme von FL-MTX im Ratten-CP ist ebenfalls Na+-abhängig, der 
basolaterale Efflux ist potentialunabhängig und erfolgt wahrscheinlich auch über Mrp1 und 
Oatp2. PKA-Aktivierung führt zu einer Aktivierung des FL-MTX Effluxes. Im Dornhai 
wird FL-MTX durch die gleichen Transportproteine transportiert. Im Gegensatz zur Ratte 
führt eine PKA-Aktivierung zu einem reduzierten Efflux von FL-MTX, während PKC-
Aktivierung zu einer Herabregulierung des Transports von FL-MTX führte. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Reichel, Valeska, Pharmacist, Oral Eximination: 13.02.06 
Molecular and Functional Analyses of Transport Proteins for Organic Anions 
Supervisor: Prof. Dr. Gert Fricker, Co-Supervisor: Prof. Dr. Ulrich Hilgenfeldt 
The blood-cerebrospinal fluid (CSF)-barrier (CSFB) is formed by the Choroid Plexūs (CP). 
Together with the blood brain barrier it represents an important barrier between brain and 
circulating blood. Since it can only be passed by small, lipid-soluble and uncharged molecules 
it is of particular interest to study active transport processes for charged substances across this 
tissue, especially because many drugs are substrates for these transport proteins. Transporters 
in the CP are similar to those in the kidney. Therefore, I performed comparative experiments 
with model organic anions in isolated proximal kidney tubules of killfish and CP of rat and 
spiny dogfish shark.  
• First, I studied transport of the fluorescent cAMP analog fluo-cAMP. Inhibition studies 
indicate transport mediated by the export proteins Mrp2 and Mrp4. In contrast to transport 
of the Mrp2-substrate fluorescein-methotrexate (FL-MTX), transport is not regulated by 
proteinkinase (PK) A, and PKC. For better characterization of kinetic parameters I studied 
transport of fluo-cAMP in membrane vesicles of MRP2 and MRP4 overexpressing cells. 
Both MRPs transported fluo-cAMP with similar affinites. Different from results obtained 
from experiments using renal proximale tubules, fluo-cAMP transport in CP seems not to be 
mediated by Mrp4, whereas a participation of Mrp1 is likely. Regulation of fluo-cAMP 
transport in rat CP is not mediated by PKA, PKC or mitogen activated PK (MAPK). 
• Transport of Texas Red (TR) and FL-MTX was studied in CP of rat and spiny dogfish 
shark. Transport of TR across rat CP is a two-step mechanism, which is metabolism-driven, 
Na+-dependent, potential independent and also independent from Mrp1, Mrp2 and Mrp4. In 
dogfish shark CP TR transport is Na+-independent, with apical uptake apparently mediated 
by an Oat-protein, whereas basolateral efflux seems to be mediated by Oatp2 and Mrp1. 
• Apical uptake of FL-MTX in rat CP is also Na+-independent with an potential independent 
basolateral efflux, which is presumably mediated via Mrp1 and Oatp2. Activation of PKA 
results in an activation of FL-MTX efflux. In dogfish shark FL-MTX is transported via the 
same transport proteins. But in contrast to rat CP, activation of PKA results in a reduced 
efflux of FL-MTX, whereas activation of PKC leads to a downregulation of FL-MTX 
transport.       
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1 Introduction 
 
1.1 Barriers to the Brain 
The homeostasis in the brain is a crucial factor for correct neurone function because the brain 
is very sensitive to changes in the surrounding environment and the extracellular milieu. 
Substance exchange is a critical factor for brain homeostasis and most water soluble 
substances can hardly enter the brain by passive diffusion, or be removed, to ensure stability 
in the composition of brain fluids. Removing metabolites or xenobiotics actively from the 
brain is an important protective mechanism (Johanson, 1998; Haselbach et al., 2001; 
Spector/Johanson, 1991). 
Due to these active mechanisms, pharmacotherapy of brain diseases including brain cancer, 
HIV, schizophrenia, meningitis, depression or epilepsy is difficult, because most of the drugs 
cannot advent their targets in the central nervous system (CNS) (Bachmayer et al., 2005; 
Ghersi-Egea/Strazielle, 2001; Löscher/Potschka, 2005; Miller, 2004). 
To provide environmental stability, the barriers in the brain work together to maintain 
homeostasis of extracellular fluid (ECF). Two barrier systems are present in the brain to 
regulate substance distribution between blood stream and CNS: the blood-brain-barrier (BBB) 
and the blood-cerebrospinal fluid (CSF)-barrier (BCSFB). The BBB is formed by the brain 
capillaries, which form a network all-over the brain and almost reach the neurons. Brain 
capillary endothelial cells act as direct barrier between blood and brain tissue. Barrier function 
of the blood-brain barrier is composed of tight junctions between endothelial cells, low 
endocytosis rate and specific transport and carrier molecules. Astrocytes, pericytes and the 
extracellular matrix components control the integrity of this barrier (Gloor et al., 2001; 
Haselbach et al., 2001; Löscher/Potschka, 2005; Nilsson et al., 1992; Spector/Johanson, 
1991). 
The second important barrier in the brain is the BCSFB comprised of the choroid plexuses 
(CPs) and the arachnoid membrane which coats the brain. Barrier function is formed by 
choroid plexus epithelial cells. The arachnoidea is only a passive barrier, which is 
unpermeable for water-soluble substances. (Haselbach et al., 2001; Johanson, 1998; Nilsson 
et al., 1992; Spector/Johanson, 1991). Figure 1 shows the different barrier compositions of 
BBB and BCSFB.  
 Introduction 
2 
Figure 1: Capillaries at the BBB (a), BCSFB (b ) and other tissues (c). At the BBB brain capillary endothelial 
cells are connected to each other by tight junctions, which prevent substance exchange through the paracellular 
route. At the BCSFB capillaries are fenestrated, tight junctions between CP epithelial cells form the barrier. In 
other capillaries free substance exchange between capillary facing solutes is possible. Figure is modified from 
Kusuhara/Sugiyama, 2001. 
 
Between brain fluids, CSF and ECF, substances can pass unhampered by simple diffusion. 
But also to and from the compartment of intracellular fluid (ICF) a permanent fluid flow takes 
place. Substance exchange between ECF and ICF or CSF and ICF is driven by selective 
transport mechanisms as in the barriers between blood and brain, because the ICF 
compartment is separated from ECF and CSF through the plasma membrane (Nilsson et al., 
1992). In Figure 2 the different compartments and possibilities for substance exchange are 
shown. 
Figure 2: The different fluid compartments in the brain. Substance exchange is unhampered between ECF and 
CSF and driven by selective mechanisms between CSF and ICF, ECF and ICF, CSF and blood and ECF and 
blood. ECF: extracellular fluid, ICF: intracellular fluid, CSF: cerebrospinal fluid. Figure is modified from 
Nilsson et al., 1992. 
 
 
1.2 Choroid Plexus Anatomy 
In all mammals, except for Amphioxus, the CPs are present and localized to the third and 
fourth ventricles of the brain and to the lateral ventricles of each hemisphere (Alebouyeh et 
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al., 2003; Nilsson et al., 1992). 90% of CP mass are located to equal parts in the lateral and 
third ventricles, only 10% are in the forth ventricle (Johanson, 1999). Localization of CPs in 
mammalian brains is shown in Figure 3. 
Figure 3: Localization of CPs in the brain. The CPs are located to the ventricles as shown below. Figure from: 
Nervous System Form and Function (colorado/edu). 
 
CP tissue is a leaf-like, highly vascularized tissue. The CPs are composed of fine blood 
capillaries surrounded by a monolayer of CP epithelial cells (Spector/Johanson, 1991). The 
epithelial cells are connected to each other by tight junctions which are very leak-proof. 
Different to those of the BBB, capillaries of the CPs are fenestrated and thus admit the 
passage of macromolecules into surrounding tissue. The surface area of the CP is increased by 
numerous villi. Each villus is composed of a single epithelium underlying the highly 
vascularized supporting tissue (Nilsson et al., 1992). The adjacent ependymal cells coat the 
ventricles and are more permeable than CP epithelial cells, they separate CSF and nerve 
tissue, the ependymal cells form a monolayer as well. At the outside of the brain, the pia-glial 
membrane forms the interface between CSF and neighbouring cortical tissue. Together with 
the arachnoidea, the pia-glial membrane constitutes the meningeal, composed of dura mater 
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and pia mater. Different to CP epithelial cells, ependymal and pia-glial cells are connected to 
each other by gap junctions. Gap junctions form a partial belt around cells and are more 
permeable than tight junctions. Unhampered diffusion from CSF across the ependymal and 
pia-glial cells is possible, thereby substances can reach their targets in the CNS, e.g. neurons 
or glia cells (Johanson, 1995; Nilsson et al., 1992; Spector/Johanson, 1991). Figure 4 shows a 
villus with surrounding CP epithelium and vicinal ependyma. 
Figure 4: A single CP villus consisting of a blood capillary surrounded by a single layer of CP epithelial cells. 
CP epithelial cells are connected to each other by tight junctions which prevent free molecule exchange. Next to 
CP epithelial cells the ependyma is shown. Ependymal cells form a monolayer as well but are connected to each 
other by gap junctions, an unhampered substance exchange is assured. Figure from Anatomy and Physiologie of 
Blood CSF barrier, arizona/edu. 
 
 
1.3 Morphology of Choroid Plexus Epithelial Cells 
CP epithelial cells are polarized, at the basolateral mebrane they have contact to the blood, the 
apical membrane faces the CSF (Johanson, 1995). In its ultrastructure CP epithelial cell 
membrane shows basal infoldings and apical microvilli. These membrane modifications are 
characteristic for transporting ephithelia (Cserr, 1971). Ultrastructurally CP epithelial cells are 
similar to the kidney epithelium (Johanson, 1995). Due to the well-developed microvilli at the 
apical membrane, surface of CP epithelium is strongly magnified. Previous assumptions 
compare surface of the BBB and BCSFB with a ratio of 5000:1, but by the increase of CP 
epithelial membrane due to microvilli, the ratio was corrected to 2:1. CP epithelial cells are 
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characterized by large, round nuclei, plenteous mitochondria and rough endoplasmatic 
reticulum (Nilsson et al., 1992).  
 
1.4 Choroid Plexus Function 
Several functions are described for CP tissue, which depend primarily on the epithelium. As 
described above an important function of CP epithelium is the barrier function which is a 
physical function. Only lipophilic substances can pass through the barrier, while hydrophilic 
substances and macromolecules are excluded from the brain. Water-soluble substances or 
macromolecules can overcome the barrier only by active and specific transport systems. A 
small leak of the described substances can occur in the brain, this leak is somewhat larger for 
CP epithelial cells than for the endothelial cells of the BBB. CP epithelium has vital functions 
as well. Many substances that are necessary for maintenance of the brain are transported 
actively through CP epithelium. CP epithelium supplies brain with vitamines (e.g. thiamine, 
vitamine B1), glucose, ribonucleosides, desoxyribonucleosides and amino acids (Nilsson et 
al., 1992; Spector/Johanson, 1991). 
CSF secretion is one of the most important functions of the CP. The secretory morphology of 
the epithelium, the localization of Na+/K+-ATPase to the apical membrane and analyses of 
freshly secreted fluid from the CP gave evidence that CP secretes CSF (Cserr, 1971; Nilsson 
et al., 1992). Now it is generally agreed, that the CP is the major site of CSF production. 90% 
of CSF are produced by the CPs, only 10% are secreted by extrachoroidal sources (Cserr, 
1971). The main extrachoroidal source are probably the endothelial cells of brain capillaries 
which form the BBB. In mammals the turnover rate of CSF is high, about 0.5 % of the total 
volume per minute or 4-5 times the total volume per day (Nilsson et al., 1992). The way of 
CSF flow was described by Fishman, 1992: CSF is produced by CP epithelial cells and 
circulates from the telencephalon to the rombencephalon into subarachnoidal spaces and then 
to the forth ventricle, the sisterna magna and basal cisterns. The circulation is followed by 
absorption into the venous blood via arachnoid villi. The CSF is a clear, colourless solution 
with a constant pH of 7.35. It is composed of 99% water and 1% micronutrients and proteins, 
these ingredients are taken from the blood. For absorption of these substances a strong blood 
flow is required, needed are four to five millimeters per minute per gramm tissue. Water is 
secreted by CP epithelium by constitution of an ionic concentration gradient at the 
membranes between epithelial cells. The liquor composition is permanent almost identical, 
independently from concentrations in the flowing blood (Spector/Johanson, 1991). The main 
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constituents of the CSF are Na+, Cl- and HCO3-. The typical CSF composition is shown in 
Table 1. Since CP epithelial cells are the major site of CSF production, these epithelial cells 
play a central role in regulation of brain homeostasis, protection of the brain and excretion of 
metabolites (Haselbach et al., 2001; Nilsson et al., 1992). CP tissue is not only a source for 
the CSF and with it nutrients and proteins, it also clears the CSF from proteins and 
metabolites (Johanson, 1999). 
Table 1: Typical composition of CSF produced by CP epithelium. Major ingredients are Na+, Cl- and HCO3-. 
The table is modified from Fishman, 1992. 
Elektrolytes (mEq/l) Amino Acids (µM) 
Na+ 138 Alanine 26.0 
K+ 2.8 Arginine 22.4 
Cl- 119 Aspartic Acid 0.2 
HCO3- 22 Aparagine 13.5 
Ca2+ 2.1 Glutamic Acid 26.1 
Mg2+ 2.3 Glutamine 552 
PO4- 0.5 Glycine 5.9 
Metabolites (mM) Histidine 12.3  
Glucose 3.3 Isoleucin 6.2  
Lactate 1.6 Leucine 14.8  
Pyruvate 0.08 Lysine 20.8  
Urea 4.7 Methionine 2.5  
Creatinine 0.09 Ornithine 3.8 
Proteins (mg/l) Phenylalanine 9.9 
Albumin 155 Phosphoserine 4.2 
IgA 1.3 Serine 29.5 
IgG 12.3 Taurine 7.6 
IgM 0.6 Threonine 35.5 
Transferrin 14.4 Tyrosine 9.5 
Total protein 350 Valine 19.9 
 
CP epithelium is also a site for synthesis and secretion of plasma proteins as transferrin, 
ceruloplasmin, cystatin C and ß2-microglobulin. These polypeptides are known to be 
synthesized in CP and brain parenchyma. Several proteins are synthesized exclusively in CP 
epithelium, including transthyretin (TTR, prealbumin), IGF-II (Nilsson et al., 1992), 
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cytokines, growth factors and neuropeptides (Chodobski/Szmydynger-Chodobska, 2001). 
Table 2 shows a list of polypeptides previously found in CP epithelium. 
Table 2: Polypeptides previously found in CSF. Several of these polypeptides are actively secreted by CP 
epithelium. Table modified from Chodobski/Szmydynger-Chodobska, 2001. 
Polypeptide Secretion by CP 
Adrenomedullin Yes 
Apolipoprotein J/clusterin  
ß-Amyloid precursor protein  
Basic fibroblast growth factor/fibroblast 
growth factor-2 
 
Brain-derived neurotrophic factor  
ß-Trace protein/prostaglandin D synthase Yes 
Cystatin C  
Endothelin 1 Yes 
Hepatocyte growth factor  
Insulin-like growth factor-II Yes 
Insulin-like growth factor binding protein 2-6 Yes 
Interleukin-1ß  
Nerve growth factor   
Neurothrophin-3 and 4  
Transferrin Yes 
Transforming growth factor-ß (isoforms ß1, 
ß2, ß3) 
 
Transthyretin/prealbumin Yes 
Tumor necrosis factor-α  
Vascular endothelial growth factor  
Vasopressin Yes 
 
The CP is a target for exogenous and endogenous polypeptides as well. Various polypeptide 
receptors are expressed in CP epithelium (Table 3). The substrates to these polypeptide 
receptors seem to have a function in controlling the secretory function of CP epithelium. 
Some of the blood-born or centrally released peptides are potent regulators of CSF formation, 
whereas the importance of this physiological role is not fully understood. A role of these 
polypeptides in CP hemodynamics and endocrine regulation is suggested, too 
(Chodobski/Szmydynger-Chodobska, 2001, Nilsson et al., 1992). 
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Table 3: Polypetide receptors located to CP epithelium and their ligands. Some ligands are supposed to be 
modulators of CSF formation and secretion by CP epithelium, but the physiological role is not fully understood. 
Table modified from Chodobski/Szmydynger-Chodobska, 2001; Nilsson et al., 1992. 
Ligand Receptor 
Acetylcholine Muscarinic receptor 
Angiotensin II AT1A, AT1B 
Apolipoprotein E apoER2 
Apolipoprotein J/clusterin gp330/megalin 
Atrial natiuretic peptide, Brain natiuretic 
peptide 
NPR-A, NPR-C 
Bradykinin B2 
Brain-derived neurothrophic factor TrkB, p75NTR 
Corticotropin-releasing factor CRF-R2 
Dopamine D1 
Endothelin ETA, ETB 
Fibroblast growth factor FGFR1, FGFR2 
Gamma-aminobutyric acid GABA A 
Growth hormone GHR 
Histamine H2 
5-Hydroxytryptamine 5-HTIC 
Insulin Insulin receptor 
Insulin-like growth factor I and II IGF-1R, IGF-2R, Man 6-P 
Interleukin-1 IL-1R1 
Leptin OB-Rb, OB-Rc, OB-Rf 
Melatonine Melatonine receptor 
Nerve growth factor P75NTR 
Noradrenaline ß1, ß2 
Prolactin PRL-R 
Transforming growth factor-ß TßRII 
Tryptamine T-2 
Vascular endothelial growth factor VEGFR-1, VEGFR-2 
Vasoactive intestinal polypeptide VIP1, VIP2- 
Vasopressin V1a, V1b 
 
Many xenobiotics underly metabolic processes that reduce their toxicology or 
pharmacological activity or rather increase their water solubility and subsequently allow their 
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renal or hepatic elimination. This biotransformation consists of two phases: phase-I and 
phase-II metabolism. Phase-I reactions are biotransformations that alter xenobiotic molecules 
by oxidation, reduction or hydrolysis. One of the most important phase-I reactions is 
oxidative biotransformation by monooxygenases that contain hemproteins of cytochrome P-
450 type. Several isoenzymes of cytochrome P-450 are known, which are structured in 
different subfamilies and families. Phase-II is a conjugation reaction: xenobiotic molecules or 
phase-I metabolites are coupled to endogenous substances. Enzymes concerned with phase-II 
biotransformations are specific transferases. Most phase-II conjugates are acids that can be 
eliminated easily (Mutschler, 1997). Drug metabolism takes place especially in kidney, liver 
and gut, but also in CP drug metabolizing enzymes were found. Thus, CP epithelium 
represents not only a physical, but also an enzymatic barrier. In CP epithelium the isoforms 
CYP 2B1,2 and CYP 1A1 of the phase-I enzyme cytochrome P-450 were detected. Other 
phase-I metabolizing enzymes found in CP are monoamine oxidase and the membrane-bound 
form of epoxide hydrolase. Phase-II metabolizing enzymes in CP epithelium include the 
cerebral form of UDP-glucuronosyltransferase, glutathione-S-transferases (GST) isoforms α, 
µ, π and glutathione peroxidase. Therefore, CP epithelium is an important site for 
detoxification of xenobiotics (Ghersi-Egea/Strazielle, 2001).  
 
1.5 Transport Mechanisms at the Choroid Plexus 
Substance permeation through lipoid membranes can follow different mechanisms. These 
different mechanisms are important for substance transport through CP epithelium, on one 
hand for supplying the brain with substances from blood, on the other hand for elimination of 
eventually toxic metabolites out of the CNS. 
Passive diffusion is energy-independent, substance transport takes place along a concentration 
gradient. Passive diffusion depends on concentration gradient, membrane area, membrane 
diameter, partition coefficient and diffusion coefficient of the substance. For diffusion 
through lipoid membranes lipid solubility, charge and molecular size of a substance are the 
crucial factors. Diffusion processes cannot be inhibited competetive or by metabolic 
inhibitors. Facilitated diffusion is mediated by carriers, driving force is the concentration 
gradient between two compartments. Substances with low membrane permeability correlate 
with carrier molecules and the complex can diffuse through the membrane. This process is 
selective and saturable, carrier mediated diffusion can be inhibited competetively, but not by 
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metabolic inhibitors. Further transport mechanisms are pinocytosis, phagocytosis and 
persorption. 
Different to passive diffusion, active transport processes are against a concentration gradient 
and energy dependent with, e.g. ATP as source of potential energy. Because of the energy 
dependency active transport processes can be inhibited competetive and by metabolic 
inhibitors (Mutschler, 1997). 
In CP tissue the brush border membrane (BBM) faces the CSF and the basolateral membrane 
(BLM) faces the blood. Tight junctions between the cells prevent free exchange of 
compounds between blood and CSF (Kusuhara et al., 2004). Only small-sized, uncharged and 
lipid-soluble substances can diffuse through CP epithelial cells. Other compounds have to be 
transported actively through the polarized epithelial cells. These transport processes are 
composed of three steps: uptake into the cell at the apical membrane of CP epithelial cells, 
crossing the cytoplasm and efflux at the basolateral membrane of the cell or the other way 
round. The molecular basis for transport are multiple groups of transport proteins expressed in 
CP epithelium. For most water soluble substances, that cannot pass the epithelium through 
passive diffusion, both transmembrane steps are mediated by transporters, different transport 
proteins are involved in uptake and efflux step. Table 4 shows transport proteins expressed in 
CP epithelium in rat. Transport processes can be visualized by confocal laserscanning 
microscopy. The distribution of different fluorescent molecules can be chased and quantified 
using this tool. Formerly radiolabeled substances were used to analyze transport processes in 
CP epithelium, but only accumulation in the whole tissue can be measured, seeing that only 
apical transport processes can be assessed. With confocal laserscanning microscopy the whole 
three-step mechanism composed of apical uptake, intracellular crossing through the 
cytoplasm and basolateral efflux can be traced (Miller, 2004). 
 
1.6 Transporters for Organic Anions 
As shown in Table 4 several transport proteins are localized to CP epithelium. Time and again 
new organic anion transporters are cloned, characterized and shown to be expressed in CP 
epithelial cells. A part of the transporters is already localized to either the apical or basolateral 
membrane of CP epithelium. All these transporters, localized asymmetrically to the polarized 
epithelium, drive concentrative, energy dependent, vectorial transport (Kusuhara et al, 2004; 
Miller, 2004). 
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Table 4: Major active transport proteins that are located to the CP of rats. Localization is identified for a few 
transporters, for most of them localization remains to be analyzed. BLM: basolateral membrane; BBM: brush 
border membrane, ND: not detected. Table modified from Choudhuri et al., 2003; Kusuhara et al., 2004; Leggas 
et al., 2004, Rao et al., 1999. 
Name Gene symbol Localisation 
Organic anion transporting polypeptide 
(Oatp) family 
  
Oatp2 Slco1a4/Oatp1a4 BLM 
Oatp3 Slco1a5/Oatp1a5 BBM 
Oatp9/moat1 Slco2b1/Oatp2b1 ND 
Oatp12 Slco4a1/Oatp4a1 ND 
Oatp14/BSAT1 Slco1c1/Oatp1c1 ND 
Organic anion transporter (Oat) family   
Oat1 Slc22a6 ND 
Oat2/NLT Slc22a7 ND 
Oat3 Slc22a8 BBM 
Organic cation transporter (Oct) family   
Oct 1a) Slc22a1 ND 
Oct 2a) Slc22a2 BBMb) 
Oct3 Slc22a3 ND 
Octn family   
Octn1 Slc22a4 ND 
Octn2/CT1 Slc22a5 ND 
Peptide transporter   
Pept2 Slc15a2 ND 
ABC transporter: P-glycoprotein   
Mdr1a Abcb1a Subapicala)  
Mdr1b Abcb1b Subapicala) 
Mdr2 Abcb2 ND 
Multidrug resistance protein (Mrp) family   
Mrp1 Abcc1 BLM 
Mrp2 Abcc2 ND 
Mrp3 Abcc3 ND 
Mrp4 Abcc4 BLM 
Mrp5 Abcc5 ND 
Mrp6 Abcc6 ND 
a)controversial b)localization of the chimeric protein (rOct2-GFP)  
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Often these transporters exhibit overlapping substrate specificities. For this reason it is 
difficult to identify transport proteins involved in transport of specific anionic xenobiotics or 
metabolites. In Figure 5 transport proteins and their different mechanisms of transport 
mediation are shown. Active and passive transport mechanisms are pictured, passive transport 
is energy-independent and follows a concentration gradient as described above. Active 
transport proteins can be classified in ion coupled transporters, influx or efflux transporters or 
exchangers (Hediger et al., 2004; Kusuhara et al., 2004; Miller, 2004).  
Figure 5: Transport proteins of the SLC family and different transporters. SLC transporters are membrane-
bound, either located to the plasma membrane or in intracellular compartment membranes. Passive transporters, 
ion coupled transporters and exchanger belong to the SLC transporter family. The non-SLC transport proteins as 
ABC transporters, ATP-dependent efflux pumps, ion channels and water channels can also be expressed in 
intracellular compartments. Figure from Hediger et al., 2004. 
 
 
1.6.1 Solute Carrier (SLC) Family 
Currently, the gene superfamily of solute carriers (SLC) consists of 43 families and 298 
transporter genes, but constantly new transporters of the SLC family are identified. The SLC 
family include genes encoding passive transporters, ion coupled transporters and exchangers, 
transport proteins are membrane-bound. Transport proteins belong to the SLC family when 
20-25% of amino acid sequence is identical to those of other proteins of the SLC family. 
Gene defects in numerous members of the SLC family are shown to play a role in different 
diseases. A number of transporters are important for pharmaceutical perspectives. 
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Transporters belonging to the SLC family can mediate uptake into the cell, efflux out of the 
cell or act as exchangers. Glucose transporters, neurotransmitter transporters, intestinal bile 
acid transporters and cation-Cl- cotransporters are used as drug targets (Hediger et al., 2004). 
In CP epithelium several members of the SLC family are expressed. Most of these 
transporters are detected at mRNA level, localization to the basolateral or apical membrane of 
CP epithelial cells remains to be analyzed (Choudhuri et al., 2003). As shown in Table 4, SLC 
transporters of the families Slco, Slc15, and Slc22 are expressed in CP. 
 
1.6.1.1 The Organic Anion Transporting Polypeptide Family (Slco) 
Fourteen members of the organic anion transporting polypeptide (Oatp) family have been 
identified in rodents (Hagenbuch et al., 2003). In rat CP epithelium rOatp3 (Slco1a5, 
Oatp1a5) is the most abundant isoform which is located to the BBM (Kusuhara et al., 2003). 
Expression of other isoforms in rat CP was analyzed: rOatp2 (Slco1a4, Oatp1a4), rOatp9 
(Slco2b1, Oatp2b1), rOatp12 (Slco4a1, Oatp4a1) and rOatp14 (Slco1c1, Oatp1c1) were 
detected, mRNA expression of rOatp4 (Slco1b2, Oatp1b2), rOatp5 (Slco1a6, Oatp1a6) and 
rOat-K1/Oat-K2 (Slco1a3, Slco1a3) was below detection limit. According to expression on 
mRNA level, expression of rOatp9, rOatp12 and rOatp2 in rat CP is much lower than 
expression of rOatp3 (Choudhuri et al., 2003).  
rOatp3 cDNA encodes a 670-amino acid protein of approximately 80 kDa with 12 putative 
transmembrane domains. The tissue distribution of rOatp3 is still under discussion, northern 
blot analyses using the 3’ non-coding region as probe detected rOatp3 expression in the 
kidney (Abe et al., 1998), analyses using the RNase protection assay revealed rOatp3 
expression in the brain, small intestine, lung and retina, but no expression in kidney or liver 
(Walters et al., 2000). Quantification of Oatp3 mRNA expression using the branched DNA 
signal amplification method revealed abundant expression in the lung, cerebrellum and female 
cerebral cortex and expression to a lesser extent in the intestine (Li et al., 2002). rOatp3 has a 
broad substrate specificity including amphipatic organic anions as bile acids, estradiol-17ß-D-
glucuronide (E217ßG), estrone sulfate (ES), dehydroepiandrosterone sulfate (DHEAS) and 
thyroid hormones (Abe et al., 1998; Cattori et al., 2001; Kusuhara et al., 2003; Ohtsuki et al., 
2003).  
The cDNA for Oatp2 encodes a 661-amino acid protein with a molecular mass of 92 kDa 
(Reichel et al., 1999). Substrate specificity of rOatp2 is similar to that of rOatp1 and rOatp3 
with a higher affinity to cardiac glykosides such as ouabain and digoxin (Cattori et al., 2001). 
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Further substrates of rOatp2 are bulky organic cations as N-(4,4-azo-n-pentyl)-21-
deoxyajmalinium, N-methyl-quinidine, N-methyl-quinine, rocuronium and anionic peptides 
as BQ-123, [D-Pen2,D-Pen5]enkephalin and deltorphin II (Gao et al., 2000). rOatp2 is a 
bidirectional transport protein (Li et al., 2000) that is expressed to the BLM of CP epithelium. 
In CP epithelium rOatp2 seems to be involved in the excretion of its substrates out of the CNS 
into blood, but also in uptake from the blood into epithelial cells (Kusuhara et al., 2004).  
rOatp9 is ubiquitously expressed in the body. In rat brain rOatp9 is expressed in the neuronal 
cells of the CNS, especially in hippocampus and cerebrellum, but expression was below 
detection limit in rat CP using northern blots and in situ hybridization (Nishio et al., 2000). 
However, Choudhuri et al. (2003) detected mRNA of rOatp9 in CP tissue. Substrates of 
rOatp9 include prostaglandins (PGE2, PGD2 and PGE1), leukotriene C4 (LTC4) and 
thromboxan B2 (Kobayashi et al., 2003). 
rOatp12 is the rodent analog of hOATP-E, the only know substrate of rOatp12 is 
triiodothyronine (T3), whereas the human analog transports T3, thyroxine (T4), reverse T3 
and E217ßG (Sato et al., 2003). 
rOatp14 was primarily identified as BBB-specific anion transporter 1 (BSAT1) (Li et al., 
2001), its cDNA consists of 2148 base pairs (bp) that encode a 716 amino acid protein with 
12 putative membrane-spanning domains. Substrates of rOatp14 are organic anions as 
E217ßG, cerivastatin and troglitazone, as well as T4 and reverse T3. T4 is the substrate which 
shows highest affinity to rOatp14 among its mentioned substrates. Sugiyama et al. could 
detect protein expression of rOatp14 in CP using western blot analyses (Sugiyama et al., 
2003). 
 
1.6.1.2 The Proton Oligopeptide Cotransporter Family (Slc15) 
The Slc15 gene family encodes for peptide transporters. In rat CP Pept2 (Slc15a2) has been 
located to the apical membrane of CP epithelial cells. Different to Pept1 (Slc15a1), which is 
expressed to highest rates in small intestine, gonards and kidney in rat, Pept2 expression is 
highest in kidney, brain and lung (Lu/Klaassen, 2005). In kidney proximal tubules epithelium 
Pept2 is located to the brush border membrane as well as Pept1, but Pept1 is located to the S1 
and S2 segment of kidney proximal tubules whereas Pept2 is located to the S3 segment 
(Russel et al., 2002). Pept2 is an electrogenic H+-dependent cotransporter which mediates 
transport of its substrates in a Na+-dependent manner. Pept2 accepts di- and tripeptides as well 
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as peptide-mimetic drugs, such as ß-lactam antibiotics containing an α-amino-group as several 
penicilline and cephalosporine as substrates. Further substances transported by Pept2 include 
angiotensin-converting enzyme inhibitors (Kusuhara et al., 2004) and valacyclovir. Pept2 
mediated transport processes can be inhibited by ampicillin, amoxicillin, cyclacillin, 
cephalexin, cefadroxil, cephradine, cefdinir, ceftibuten, cefixime and bestatin. The transporter 
Pept1 has a similar substrate spectrum including glycylsarcosin (GlySar), 5-aminolevulinic 
acid (5-ALA), cefixime, L-Dopa-L-Phe and Val-azidothymidine. In the intestine Pept1 may 
contribute to the intestinal absorption of orally administered xenobiotics, whereas Pept1 and 
Pept2 in the kidney may play a role in accumulation of glomerular-filtered xenobiotics 
(Russel et al., 2002). The functional role of Pept2 in CP epithelium was analyzed by 
Ocheltree et al. (2004). In gene knockout mice they had the possibility to analyze function of 
one transport protein that belongs to multiple gene families. The results of transport studies in 
Pept2 null animals in comparison to wild-type mice indicate that active uptake of GlySar was 
reduced about 95 % in Pept2 null mice. Similar results were found for active uptake of the 
peptidomimetic compound 5-ALA, 5-ALA uptake was reduced about 92 % in Pept2 null mice 
compared to wild-type animals. Taken together the results give evidence that Pept2 is the sole 
transporter for transport of 5-ALA and GlySar in CP. Pept2 seems to play an important role in 
the trafficking of endogenous and exogenous peptidomimetics and polypeptides between CSF 
and blood (Ocheltree et al., 2004).  
 
1.6.1.3 The Organic Ion Transporter Family (Slc22a) 
The organic ion transporter family is a superfamily composed of organic anion transporter 
(Oat, Slc22a), organic cation transporter (Oct, Slc22a), carnitine/organic cation transporter 
(Octn, Slc22a), CT2 and URAT1. CT2 is a transporter for carnitine whereas URAT1 
transports urate. The transporters of the Oat, Oct and Octn family are of particularly interest 
for transport processes in the CP and will be detailed in the following chapters. 
 
1.6.1.3.1 Organic Anion Transporter (Oat) 
Four Oat genes have been identified, in rodents the organic anion transporters Oat1-3 and 
Oat5 are described. Choudhuri et al. (2003) detected mRNA of three Oats in rat CP: rOat1 
(Slc22a6), rOat2 (Slc22a7) and rOat3 (Slc22a8). rOat3 is the most abundant isoform in rat 
CP, followed by rOat1 and rOat2 (Choudhuri et al., 2003). Protein expression of rOat3 could 
be demonstrated using western blot analyses, but rOat1 could not be detected (Nagata et al., 
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2002). Immunolocalization showed localization of rOat3 to the BBM of the CP (Nagata et al., 
2002) and BLM of kidney proximal tubules (Russel et al., 2002). Oat3 has a broad substrate 
specificity including amphipathic organic anions as E217ßG, ES and DHEAS, hydrophilic 
organic anions as p-aminohippurate (PAH) and benzylpenicillin and the organic cation 
cimetidine (Kusuhara et al., 2004; Nagata et al., 2002; Russel et al., 2002). Oat3 mediated 
transport processes can be inhibited by i.a. probenecid, bromosulphophthalein (BSP), 
indocyanine green and furosemide (Russel et al., 2002). It is likely that rOat3 acts as an 
exchanger and an outward concentration gradient of dicarboxylates (e.g. α-ketoglutarate), 
formed by the sodium-dependent dicarboxylate co-transporter and the tricarboxylic acid or 
citric acid (TCA) cycle, drives rOat3-mediated transport (Kusuhara et al., 2004). Experiments 
with mOat3 knockout mice showed that Oat3 plays a role in transport function in CP. 
Fluorescein (FL) transport in CP was markedly reduced in CP of Oat3 knockout mice 
compared to wildtype mice (Sweet et al., 2002).  
rOat1 was described as a classical organic anion transporter in the kidney (Sweet et al., 1997). 
It is located to the BLM of kidney proximal tubules and shows a broad substrate specificity as 
well as rOat3. rOat1 substrates include organic anions as PAH, acyclovir and ß-lactam 
antibiotics as cephaloridine and benzylpenicilline, nucleoside analogs as azidothymidine 
(AZT) or 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and nonsteroidal anti-inflammatory 
drugs as salicylate and acetylsalicylate (Kusuhara et al., 2004; Russel et al., 2002; Sweet et 
al., 1997). rOat1 mediates transport processes as an exchanger (Sweet et al., 1997).  
rOat2 was registered as a novel-liver specific transporter (NLT) (Sekine et al., 1998; 
Simonson et al., 1994) with a relatively broad substrate specificity. NLT or Oat2 transports α-
ketoglutarate, prostaglandine E2 (PGE2), PAH, methotrexate (MTX) and acetylsalicylate 
(Russel et al., 2002). 
 
1.6.1.3.2 Organic Cation Transporter (Oct) 
Organic cation transporter (Oct) are multispecific facilitative transporters for hydrophilic and 
small organic cations. In rodents three isoforms have been isolated: Oct1-Oct3 (Van 
Montfoort et al., 2003). The Oct isoform expression in rat CP is controversial, Sweet et al. 
(2001) used cDNA from rat CP as a template and revealed expression of rOct2 (Slc22a2) and 
rOct3 (Slc22a3), but not rOct1 (Slc22a1) in rat CP using PCR analyses. Contrary to these 
findings, Choudhuri et al. (2003) quantified mRNA expression in rat CP and found low 
expression rates for rOct1 and rOct3 in rat CP, rOct2 expression level was below detection 
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limit. rOct1 is expressed abundantly in the kidney, liver and intestine (to a less extent) in rat 
(Grundemann et al., 1994). rOct1 is an uptake transporter and transport processes mediated by 
rOct1 are membrane voltage dependent. The Oct isoforms have a similar substrate specificity 
including small and hydrophilic organic cations as tetraethylammonium (TEA) and N-
methylnicotineamide (NMN). rOct2 exhibits a relatively lower affinity to TEA compared to 
affinities of rOct1 and rOct3 (Jonker/Schinkel, 2004). The localization of rOct1, rOct2 and 
rOct3 in CP epithelium remains to be identified. A chimeric protein of rOct2-green 
fluorescent protein fusion construct (GFP) was produced and transfected to isolated rat CP. 
The fluorescence associated with rOct2-GFP was localized to the BBM of CP epithelium, 
suggesting an apical localization of rOct2, if expressed in rat CP (Sweet et al., 2001). 
Different knockout mice have been developed recently. Mouse strains of Oct1, Oct2, Oct3 
knockouts and Oct1/Oct2 double knockout mice have been established (Jonker et al., 2001; 
Jonker et al., 2003; Zwart et al., 2001), but transport experiments in isolated CPs were not 
done by now (Kusuhara et al., 2004). 
 
1.6.1.3.3 Carnitine/Organic Cation Transporter (Octn) 
Three isoforms of the Octn family have been isolated in rodents: Octn1-Octn3 
(Koepsell/Endou, 2004). Abundant expression of rOctn2 (Slc22a5) has been demonstrated in 
rat CP, rOctn1 (Slc22a4) was detected to a lesser extent, whereas rOctn3 (Slc22a6) expression 
remains to be analyzed (Choudhuri et al., 2003). Octn2 is a sodium-dependent carnitine 
transporter (Sekine et al., 1998) which also transports TEA (Tamai et al., 2000). hOCTN1 is 
regarded to be a H+/organic cation exchanger that is multispecific and pH-dependent. 
Substrates for hOCTN1 include organic cations as pyrilamine, quinidine and verapamil as 
well as carnitine. Interestingly cation uptake mediated by hOCTN1 is sodium independent 
whereas carnitine uptake mediated by hOCTN1 shows sodium dependency (Yabuuchi et al., 
1999). 
 
1.6.2 ATP Binding Cassette Superfamily 
The ATP binding cassette (ABC) superfamily is characterized by the cytoplasmatic 
localization of the ABC and the unidirectional efflux transport of its substrates. The ABC acts 
as a catalysator for ATP hydrolysis which is essential for transport processes mediated by 
ABC transporters (Kusuhara et al., 2004). The following sections attend to the multidrug 
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resistance-associated proteins (Mrp/Abcc) and P-glycoprotein (P-gp), because expression of 
these transport proteins was previously analyzed in CP epithelium. 
 
1.6.2.1 Multidrug Resistance-Associated Proteins (Mrp/Abcc) 
Nine structurally and functionally related multidrug resistance-associated protein (MRP) 
family members have been identified (MRP1-9). The isoforms are different concerning their 
localization, expression levels, and substrate specificity (Van de Water et al., 2005). mRNA 
expression of Mrp1-Mrp6 in rat CP was investigated by Choudhuri et al., 2003. An abundant 
expression rate of Mrp1 (Abcc1), Mrp4 (Abcc4) and Mrp5 (Abcc5) was found, whereas Mrp6 
(Abcc6) showed a moderat expression. Mrp2 (Abcc2) and Mrp3 (Abcc3) expression rates in 
rat CP were very low (Choudhuri et al., 2003). Expression levels of Mrp7-Mrp9 are not 
analyzed by now. 
Mrp1 expression and localization in rat CP is well investigated. As described above, mRNA 
expression of Mrp1 is high in CP (Choudhuri et al., 2003), protein expression experiments 
using western blot analyses have localized Mrp1 to the basolateral membrane of CP 
epithelium (Nishino et al., 1999; Ohtsuki et al., 2003). The mRNA of MRP1 encodes for a 
1531 amino acid protein with an apparent molecular weight of 190 kDa and 17 
transmembrane domains with two cytoplasmically located ABCs (Cole et al., 1992). Mrp1 is 
a basolateral efflux transporter in rat CP, it has a wide substrate specificity including 
amphipathic organic anions as LTC4, E217ßG, etoposide-glucuronide and reduced 
glutathione. Mrp1 mediated transport processes can be inhibited by addition of e.g. 
probenecid, MK571, cyclosporin A, PSC833 and indomethacine (Russel et al., 2002). 
MRP4 mRNA encodes for a 1325 amino acid protein with a molecular weight of 170 kDa and 
12 putative transmembrane domains (Van Aubel et al., 2002). In CP epithelium Mrp4 seems 
to be located to the BLM (Leggas et al., 2004; present study), this colocalization to Mrp1 
indicates involvement of Mrp4 in basolateral efflux of its substrates into blood. Substrates of 
Mrp4 are the second messengers cAMP and cGMP (Chen et al., 2001;Van Aubel et al., 2002), 
it also transports acyclic nucleoside phosphonates, for example PMEA (adefovir) and 
monophosphorylated nucleoside analogs such as azidothymidine-monophosphate (AZT-MP, 
zidovudine-monophosphate) (Lee et al., 2000). In addition, Mrp4 substrates include PAH and 
methotrexate (Lee et al., 2000; Smeets et al., 2004). Mrp4 mediated transport can be reduced 
by probenecid, dipyridamole, S-(dinitrophenyl)-glutathione (DNP-SG) and other substances 
(Russel et al., 2002). Leggas et al. developed Mrp4 knockout mice and showed that topotecan 
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accumulated in brains of the knockout animals due to the absence of Mrp4 which actively 
eliminates topotecan into blood (Leggas et al., 2004). 
MRP5 gene encodes for a protein with a molecular weight of approximately 185 kDa 
(Jedlitschky et al., 2000), 1437 amino acids and 12 putative transmembrane domains (Van 
Aubel et al., 2002). Within the Mrp family Mrp5 is most closely related to Mrp4, both 
transport proteins lack the first five membrane-spanning regions and share a similar substrate 
specificity (Wijnholds et al., 2000). Substrates of Mrp5 include i.a. DNP-SG, PMEA, cAMP, 
cGMP and fluorescein-diacetate (FDA) (Russel et al., 2002). Localization of Mrp5 protein in 
rat CP remains to be established. 
Mrp6 protein consists of 1503 amino acids with three membrane spanning domains (MSD1-
3). In mice Mrp6 gene is expressed predominantly in liver and kidney, low level expression in 
other tissues was detected as well. Mrp6 substrates include glutathione conjugated to LTC4, 
N-ethylmaleimide (Matsuzaki et al., 2005) and BQ123 (Russel et al., 2002). Moderate mRNA 
expression of Mrp6 was detected in rat CP (Choudhuri et al., 2003), but protein expression or 
localization remains to be analyzed.  
 
1.6.2.2 P-Glycoprotein (P-gp/ABCB1) 
P-gp gene encodes for a 1289 amino acid protein with a molecular weight of approximately 
140-170 kDa and 12 transmembrane domains with two cytoplasmically located ATP-binding 
cassettes. In rodents two isoforms, Mdr1a (Abcb4) and Mdr1b (Abcb1), are commensurate to 
the human ortholog MDR1. Mdr1 is an important efflux transport protein involved in 
multidrug resistance in brain capillary endothelial cells forming the BBB and in the small 
intestine (Schinkel et al., 1994). Substrate specificity of P-gp is broad and includes 
hydrophobic neutral or cationic substances, i.a. fexofenadine, E217ßG, cancer drugs as 
doxorubicine, vincristine, immunosuppressive drugs as cyclosporin A, HIV protease 
inhibitors such as ritonavir and saquinavir and cardiac drugs like quidine. P-gp activity can be 
reduced by addition of several inhibitors as verapamil, cyclosporine A, mifepristone and 
quinidine (Sun et al., 2003). At the BBB P-gp is an efflux transporter of particular interest, 
because it plays a major role in the phenomen of multidrug resistance, many pharmaceutical 
drugs cannot overcome the BBB because they are transported out of the brain capillary 
endothelial cells back into blood by P-gp (Löscher/Potschka, 2005). 
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In CP epithelium P-gp seems to be located subapical, Rao et al.(1999) detected this 
localization in primary cell cultures of rat CP epithelial cells grown on filters. In a previous 
study we approved this localization in isolated rat CPs, no functionality could be verified 
using porcine CP cell culture (Reichel et al., 2004). 
 
1.7 Localization of Organic Anion Transporters 
 
Due to the number of different transport proteins and varieties in substrate specificities, it is 
important to localize these transporters to the different membranes of polarized cells. In CP 
epithelium the basolateral membrane faces the blood, whereas the apical membrane faces the 
CSF. Not much is known about localization of transport proteins in the CP, transporters with 
known localizations are shown in Figure 6.  
Figure 6: Localization of transport proteins in CP epithelium. Oat3 and Oatp3 are located to the apical 
membrane, whereas Oatp2, Mrp1 and Mrp4 are located to the basolateral site. Only tranporters are shown that 
are clearly localized to one membrane by immunostaining. 
 
The exchangers Oat3 and Oatp3 are located to the apical membrane of CP epithelial cells, 
Oatp2, Mrp1 and Mrp4 are located to the basolateral membrane. 
Transporter distribution in CP epithelium is partially contrary to localization in kidney 
proximal tubulus epithelial cells. In Figure 7 an assortment of transport proteins in kidney 
proximal tubulus epithelium is shown. Contrary to the findings in CP epithelium, Mrp4 is 
located to the apical membrane of kidney proximal tubules epithelial cells whereas Oat3 is 
located to the basolateral membrane (Russel et al., 2002). 
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Figure 7: Localization of transport proteins in kidney proximal tubulus epithelial cells. Localization of Mrp4 
and Oat3 is contrary to that in CP epithelium. 
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2 Purpose of the study 
Aim of the study were analyses of transport mechanisms for organic anions in different 
models, especially in CP tissue. Due to the difficult isolation and the low viability of rat CP 
tissue, different models for transport processes were used to get evidence for transport 
proteins involved in transport processes in rat CP. 
 
2.1 Fluo-cAMP Transport in Killifish Proximal Tubulus 
Due to the possibility of visualization of transport processes by confocal microscopy, one 
purpose was the investigation of Mrp4 function using the fluorescent dye fluo-cAMP. As 
cAMP is a common substrate for Mrp4 used its fluorescent analog as model substance for 
transport processes mediated by Mrp4, which is localized to the apical membrane of killifish 
(fundulus heteroclitus) proximal tubules, as shown in the present study. To analyze these 
transport processes, we performed functional analyses using fluo-cAMP as substrate and 
different inhibitors of organic anion transport in killifish proximal tubules. Furthermore we 
investigated regulatory pathways which are involved in regulation of transport of the 
fluorescent compound. Killifish kidneys contain a high fraction of proximal tubules (Evans, 
Physiology of Fishes), which can be easily isolated and are stable at room temperature for a 
long period of time. Due to the similarity between kidney and CP, concerning function and 
transport proteins expressed (Breen et al., 2004; Kusuhara et al., 2004; Miller, 2004; 
Spector/Johanson, 1991), killifish proximal tubules seem to be a good model for transport 
processes in CP.  
 
2.2 Fluo-cAMP Transport in Membrane Vesicles 
For analyses of specific transport processes mediated by MRP2 and MRP4, we used 
membrane vesicles of MRP2 and MRP4 overexpressing cells, respectively. Using this model, 
fluo-cAMP transport mediated by both MRPs could selectively be investigated. The 
advantage of using membrane vesicles of overexpressing cells is the possibility to study 
transport processes mediated by only one protein. 
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2.3 Fluo-cAMP Transport in Rat Choroid Plexus 
To examine the eligibility of the described methods as models for transport processes in CP 
tissue, we performed transport studies using fluo-cAMP as substrate in rat CP as well. 
Initially, we analyzed expression and localization of Mrp4 in rat CP and accomplished 
transport studies as described for the killifish model. For analyses of regulatory processes 
involved in transport of fluo-cAMP we researched into the effects of activators or inhibitors 
for different regulatory cascades including endothelin and mitogen-activated proteinkinase 
pathway. 
 
2.4 Texas Red Transport in Rat and Shark CP 
Dogfish shark (Squalus acanthias) CP is easily accesible, of a large size and stable for a long 
period of time. These features are reasons for the use of shark CP as a model for mammalian 
CP. We analyzed transport of the fluorescent dye texas red (TR) in CPs of both species for 
comparison of transport processes. As described above, we incubated CP tissue with TR and 
different modulators of organic anion transport to specify transport proteins involved in TR 
transport in rat and shark CP, respectively. 
 
2.5 Regulation of Fluorescein-Methotrexate Transport 
From previous studies we know that transport proteins involved in fluorescein-methotrexate 
(FL-MTX) transport in rat and dogfish shark are the same (Baehr et al., in press; Breen et al., 
2004). For further comparison of FL-MTX transport we wanted to investigate into regulatory 
pathways driving transport of FL-MTX in both species. Baehr et al. (in press) analyzed 
regulation of FL-MTX transport in dogfish shark CP, here we determined regulation of FL-
MTX transport in CPs of rats. 
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3 Materials and Methods 
3.1 Materials 
All chemicals were reagent grade or better and obtained from Sigma Chemical co. (St. Louis, 
MO/ Zwijndrecht, the Netherlands/ Steinheim, Germany) or other commercial sources. 
MDCKII-MRP2 cells were obtained from P. Borst (Dutch Cancer Institute, Amsterdam, the 
Netherlands). For fluorescence measurements in membrane vesicle studies a Shimadzu RF-
5301PC spectrofluorophotometer was used. 
The RNeasy Kit® for RNA Isolation was obtained from Qiagen GmbH (Mannheim, 
Germany). Tissue was stored in RNAlater®, obtained from Sigma-Aldrich GmbH (Steinheim, 
Germany) before RNA-Isolation. RNA was quantified using a NanoDrop® ND-3300 
fluorospectrophotometer obtained from Nanodrop Technologies (Wilmington, DE). The 
Promega Reverse Transcription System® was purchased from Promega GmbH (Mannheim, 
Germany). Ethidium Bromid was obtained from GibcoBRL (Karlsruhe, Germany). RiboLock 
ribonuclease inhibitor was purchased from Fermentas GmbH (St. Leon-Rot, Germany). 
Supertaq® was from MoBiTec GmbH (Freiburg, Germany). Primers were custom primers 
obtained from Invitrogen (Karlsruhe, Germany). Both, reverse transcription (RT) and 
polymerase chain reaction (PCR) were performed in a PCRSprint® cycler from Thermo 
Hybaid (Heidelberg, Germany). 
The used primary Mrp4 antibody in killifish experiments was a rat Mrp4 antibody (pAb rM4-
pl) raised in rabbit at the Nijmegen Centre for Molecular Life Sciences (NCMLS, Rabound 
University, Nijmegen, the Netherlands) described in Van Aubel et al., 2002. Goat derived 
anti-rabbit IgG 488 was obtained from Molecular Probes (Eugene, OR). For 
immunocytological experiments in rats, Mab to Mrp4 (M4I-80) from Alexis (Grünberg, 
Germany) and rabbit derived FITC-labeld anti-rat IgG from DAKO A/S (Glostrup, Denmark) 
were used. The fluorescence enhancer Aqua Poly/Mount was obtained from Polysciences Inc. 
(Warrington, PA). 
Male and female sprague-dawley and wistar rats were obtained from the animal faculty of the 
university of Heidelberg. TR- rats were a kind gift from Prof. Dr. Petzinger (University of 
Gießen, Germany). 
Isofluran for anaesthetizing rats was obtained from Abbott (Wiesbaden, Germany). Fluo-
cAMP and fluo-cGMP were purchased from Biolog Life Science institute (San Diego, CA/ 
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Bremen, Germany). Fluorescein-Methotrexate (FL-MTX) and phorbol-12-myristate-13-
acetate (PMA) were obtained from Molecular Probes (Eugene, OR). Texas Red (TR) was 
obtained from Sigma-Aldrich GmbH (Steinheim, Germany). MK571 was purchased from 
Biomol (Hamburg, Germany). Prostaglandin E2 was a kind gift from the group of Prof. Dr. 
Offermanns (University of Heidelberg, Germany). The radioactive [3H]-cGMP was obtained 
from Moravek Biochemicals (Brea, CA) or Amersham Pharmacia Biotech (Freiburg, 
Germany). Ultima Gold MV Liquid Scintillation Cocktail was obtained from Canberra 
Packard (Frankfurt, Germany). Radioactivity analyses were carried out in a Tricarb 2000 CA 
Scintillation Counter from Canberra Packard (Frankfurt, Germany). 
Fluorescence was visualized using Confocal Laser Scanning Microscopy. The used Confocal 
Laser Scanning microscopes were the Leica DM IRBE from Leica (Bensheim, Germany) and 
the Olympus Fluoview from Melville (NY, USA).  
 
3.2 MDCKII and Sf9-Cells 
MDCKII (Madin-Darby Canine Kidney) cells overexpressing human MRP2 were obtained 
from P. Borst (Dutch Cancer Institute, Amsterdam, the Netherlands). Sf9 (Spodoptera 
frugiperda) cells expressing human MRP4 were generated by infection of cells using a 
recombinant baculovirus encoding MRP4 or, as a control, Opsine, as described previously 
(Van Aubel et al., 2002) at the NCMLS (Rabound University, Nijmegen, the Netherlands). 
 
3.2.1 Cell Culture 
We carried out cell culture at 37°C, 5% CO2 und 95% relative humidity. Culture medium was 
composed of Dulbecco’s MEM 1x with 10 % fetal calf serum and 1 % penicillin/streptomycin 
added. Once a week cells were passaged and seeded in cell culture flasks with an area of 75 
and 175 cm2. After seven days in culture, cells were used for membrane vesicle isolation. 
 
3.2.2 Isolation of Crude Membrane Vesicles 
Infected Sf9 cells were resuspended in ice-cold homogenization buffer (0.5 mM sodium 
phosphate, 0.1 mM EDTA), supplemented with protease inhibitors (100 µM PMSF, 5 µg/ml 
aprotinin, 5 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µM E64), and shaken on ice for 1 h. Lysed 
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cells were centrifuged at 100,000 x g and 4°C and the resulting pellet was homogenized in 
ice-cold TS buffer (10 mM Tris-HEPES, 250 mM sucrose, pH 7.4) with a tight-fitting Dounce 
glass tissue grinder. The homogenate was centrifuged at 500 x g and 4°C and the resulting 
supernatant was centrifuged at 100,000 x g at 4°C. The resulting pellet was resuspended in TS 
buffer and passed 30 times through a 27-gauge needle. Aliquots of crude membrane vesicles 
were frozen in liquid nitrogen and stored at –80°C until use. Sf9 membrane vesicles were 
prepared and characterized at the NCMLS (Nijmegen, the Netherlands). 
MDCKII-MRP2 cells were directly scraped in homogenization buffer supplemented with 
protease inhibitors as described above, and centrifuged at 100,000 x g and 4°C to collect cells 
and debris. The pellet was homogenized in TS buffer, and the procedure, described for Sf9 
cells, was followed to obtain vesicles. MDCKII-MRP2 membrane vesicles were prepared and 
characterized at the NCMLS (Nijmegen, the Netherlands). ~65% of the vesicles were 
orientated inside-out. 
 
3.3 Tissues Ex Vivo 
For functional and immunocytological analyses we used freshly isolated tissues from 
killifishes, rats and dogfish sharks. All animal studies were performed in accordance with the 
rules of the local authorities for animal protection. 
 
3.3.1 Killifish Proximal Tubulus Ex Vivo 
Killifish (fundulus heteroclitus) were collected in the vicinity of Mount Desert Island, Maine. 
The fishes were held in tanks with natural flowing sea water at the Mount Desert Island 
Biological Laboratory (MDIBL). After dispatching the animals, renal tubules masses were 
extracted and carried over into petri dishes containing marine teleost saline buffer based on 
Forster and Taggart (1950) (140 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 1.0 mM MgCl2 and 
20 mM Tris at pH 8.0). All experiments were carried out at room temperature (18-25°C). 
Under a dissecting microscope, we removed adherent haematopoietic tissue with fine no. 5 
forceps and proximal tubules were transferred to a foil-covered Teflon chamber (Bionique) 
containing marine teleost saline buffer for functional or 2% (v/v) formaldehyde and 0.1% 
(v/v) glutaraldehyde for immunocytological analyses. 
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3.3.2 Rat Choroid Plexus Ex Vivo 
CPs were isolated from male and female Wistar and Sprague Dawley rats and TR- rats which 
are deficient in Mrp2. Rats were narcotized by inhaling isofluran in an exsiccator and 
sacrified by cervical dislocation. Skullcap was sliced, the brain removed and placed into 
pregassed (95% O2/5% CO2) artificial cerebrospinal fluid (aCSF) containing 103 mM NaCl, 
4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4 x 7 H2O, 25 mM NaHCO3, 10 mM 
glucose, 1 mM sodium pyruvate, 2.5 mM CaCl2 at pH 7.4. Brains were cut into halves and 
both lateral CPs were removed. Each CP was cut into two pieces and placed in pregassed 
aCSF for functional analyses or in 8% Paraformaldehyde (PFA) for immunocytological 
experiments. For gene expression experiments whole CP tissue was stored in RNAlater® at –
80°C until use.  
 
3.3.3 Dogfish Shark Choroid Plexus Ex Vivo 
Adult male and female spiny dogfish sharks (Squalus acanthias) wer collected in the vicinity 
of Mount Desert Island, Maine. Sharks were held in large tanks of flowing sea water for 1-4 
days before use. After decapitation the cranial compartment was removed immediately and 
transferred into icecold, pregassed (99% O2/1% CO2) elasmobranch ringer (ER), containing 
280 mM NaCl, 6 mM KCl, 4 mM CaCl2, 3 mM MgCl2, 1 mM NaH2PO4, 0.5 mM Na2SO4, 
350 mM urea, 72 mM trimethylamine oxide, 2.5 mM glucose, and 8 mM NaHCO3 at pH 7.8, 
and placed on ice. The brain was removed and lateral and IV CPs were extracted, adherent 
tissue was excised and CPs were given into icecold ER. Each CP was dissected in two pieces. 
 
3.4 Gene Expression 
 
3.4.1 Total RNA Isolation 
CP tissue frozen in RNAlater® was defrosted and up to 30 mg were lysed with RLT-buffer 
containing ß-mercaptoethanol in a glass-homogenizer. Total RNA was isolated from the 
samples according to the Qiagen RNeasy® manual. After homogenization with RLT-buffer 
an equal volume of EtOH 70% was added. Samples were transferred onto RNeasy® mini spin 
columns and centrifuged for 30 seconds. Samples were washed and centrifuged with different 
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buffers as described in the RNeasy® protocol. Total RNA was eluted in 30 µl of nuclease free 
H2O. The amount of total RNA in the samples was quantified using a NanoDrop® ND-3300. 
 
3.4.2 Reverse Transcription 
Total RNA was transcribed in complementary DNA (cDNA) using reverse transcriptase. 
Reverse transcription (RT) was performed using 1 µg of total RNA. The Promega 
Transcription System® was used according to the manufacturers protocol. RNA was 
preincubated at 70°C for 10 minutes. Afterwards reaction mixture, containing 4 µl 5x avian 
myeloblastosis virus reverse transcriptase (AMV-RT) buffer, 4 µl MgCl2 (25mM), 2 µl dNTP 
mixture (10mM), 1 µl oligo(dT)15 primer (500 µg/ml), 0.5 µl Rnasin® or Riboblock® 
ribonuclease inhibitor (2.5 units), nuclease free water and 1 µl (5 units) of AMV-RT, was 
added and samples incubated at 42°C for 60 minutes. For determining the reaction samples 
were incubated at 95°C for 5 minutes and afterwards cooled to 4°C. The originated cDNA 
product was not stored, but directly used for polymerase chain reaction (PCR). 
 
3.4.3 Polymerase Chain Reaction 
For amplifying special regions of engendered cDNA, polymerase chain reaction was used. A 
hot start method (described by D’Aquila et al., 1991) was performed to destroy potentially 
formed primer-template complexes and prevent extension of these complexes during 
annealing. For PCR 0.1 µg of RNA (accordant 2 µl of template) was used. Template was 
mixed with a reaction mixture (5 µl Supertaq® reaction buffer containing MgCl2 (20 mM), 
0.25 µl of forward and reverse primer (100 µM), 2 µl of dNTP mixture (10 mM) and nuclease 
free water) and incubated at 94°C. Afer 8 minutes incubation 0.5 units Supertaq® were 
added. 15 up to 50 cycles of denaturation (94°C for 30 seconds), annealing (53°C for 30 
seconds) and extension (72°C for 30 seconds) were performed. After a final extension at 72°C 
for 10 minutes, PCR products were stored at 4°C. PCR products were seperated in a 1.5% 
agarose gel, containing 10 µl ethidium bromide per 100 ml, at 100 V for 1 hour. Visualization 
was carried out using UV-light and the Quantity One® software in a ChemieDocTM XRS 
(Biorad, München, Germany).  
We used forward and reverse primer that are specific for the target sequence, nucleotide 
sequences are listed in Table 5. 
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Table 5: Specific primers for Mrp4 and Pbgd cDNA. Primers are custom primers, ascertained after a nucleotide-
nucleotide BLAST. 
Target Forward Primer (5’ to 3’) Reverse Primer (3’ to 5’) Product 
Size (bp) 
Ppgd GTGATGAAGGATGGGCAACT TTAAGGAGCACAGGGCACTT 360 
Mrp4 CCTGGTAAAATGGACACTGA CTGTTAAGGCACAAAACCTG 773 
 
3.4.4 Semiquantitative RT-PCR 
Specific PCR products were amplified according to the described methods. 15 up to 50 cycles 
of denaturation, annealing and extension were performed in 5-cycle intervals. For analyzing 
linear amplification density of PCR products, visualized by ethidium bromide binding, was 
compared. Scion Image software (NIH, USA) was used to analyze density. For 
semiquantitative RT-PCR a cycle number with linear amplification was chosen and 
expression of target gene and housekeeping gene were compared. The non-regulated, 
pseudogene free housekeeping gene, Porphobilinogen deaminase (Pbgd) was used as standard 
housekeeping gene. 
 
3.4.5 Immunocytological Staining 
Freshly isolated killifish proximal tubules and rat CP tissue were stained using different 
protocols. As described by Masereeuw et al. (2000), tubules were washed (10 mM PBS) and 
fixed for 10 min at room temperature. Fixation solution was composed of 2% (v/v) 
formaldehyde and 0.1% (v/v) glutaraldehyde. After washing 5 times with 10 mM PBS, 
tubules were permeabilized using Triton X-100 1% (v/v) in PBS for 30 min. Tubules were 
washed and incubated with the primary pAb rM4-pl antibody in PBS for 90 min at 37°C. 
After washing 5 times, tubules were incubated with the fluorescein-labeled anti-rabbit IgG 
488 for 60 min at 37°C and washed 5 times. Mrp4 localization was viewed using the Olympus 
fluoview confocal microscope. 
Rat CP tissue was fixed in 8% PFA for 30 minutes at room temperature, followed by 
permeation in Triton X-100 0.1% (v/v) for 15 minutes. After washing 3 times with aCSF CPs 
were incubated with blocking buffer (1% BSA, 1% milk powder and 5% rabbit serum) for 1 
hour. Subsequently CPs were incubated with blocking buffer (control) or Mab to Mrp4 M4I-
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80 (described in Leggas et al., 2004) diluted 1:5 in blocking buffer at 4°C overnight. CPs 
were washed 3 times with Triton X-100 0.05% and incubated with rabbit derived FITC-
labeled anti-rat IgG and 1 µM propidium iodide (PI) for 2 hours at room temperature. After 
washing 3 times with Triton X-100 and aCSF, fluorescence was visualized using the Leica 
DM IRBE confocal microscope. CPs were embedded in Aqua Poly/Mount to enhance 
fluorescence. 
 
3.5 Functional Analyses 
Functional analyses were performed to determine transport proteins and their function in 
different models. Transport of the fluorescent compounds fluo-cAMP, TR and FL-MTX as 
well as the radioactive-labeled substance [3H]-cGMP were examined in membrane vesicles, 
killifish proximal tubules and rat or dogfish shark CP. 
 
3.5.1 Uptake Studies in Membrane Vesicles 
Uptake studies were performed using fluo-cAMP and [³H]-cGMP as substrates as described in 
Smeets et al. (2004). Vesicles stored at –80°C were prewarmed for 1 min at 37°C and added 
to a mixture of TS-Buffer (10 mM Tris-HEPES, 250 mM Sucrose, pH 7.4), 10 mM MgCl2, an 
ATP-regenerating system (4 mM ATP, 10 mM creatine phosphate, 100 µg/ml creatine kinase) 
and fluo-cAMP or [³H]-cGMP, respectively. For control experiments ATP was replaced by 
5’-AMP. At indicated time points samples were taken and diluted in 900 µl icecold TS-Buffer 
to stop transport processes. Samples were filtered through NC45 filters (Whatman, 
Maidstone, UK) with a sampling manifold (Millipore, Billerica, MA). For the fluorescent 
compound filters were incubated in SDS/HEPES-Puffer (1% SDS, 7.5 mM HEPES) for at 
least 30 min. Afterwards fluid fluorescence was measured using a Shimadzu RF-5301PC 
spectrofluorophotometer (EX: 480 nm, EM: 520 nm). In experiments with [³H]-cGMP, filters 
were put into vials, 4 ml Opti-fluor were added and vials were shaken. Radioactivity was 
counted in the Scintillation counter. All experiments were performed in triplicate. 
ATP-dependent transport was calculated by subtracting values obtained in presence of 5’-
AMP from those obtained in presence of ATP. To calculate MRP2 and MRP4 specific 
transport, respectively, values for ATP-dependent transport of control vesicles were 
substracted from those of transfected cell membrane vesicles. 
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3.5.2 Transport Studies in Killifish Proximal Tubulus 
As described above proximal tubules were transferred to Teflon chambers containing 1 ml of 
marine teleost solution with or without inhibitors added. Different inhibitors of organic anion 
transport were added as stock solutions in marine teleost saline or in dimethylsulfoxide 
(DMSO). The DMSO concentration did not exceed 0.5%. This DMSO concentration had no 
effect on fluo-cAMP or FL-MTX transport (present study, Breen et al., 2004). After 30 
minutes preincubation the fluorescent compound (2 µM fluo-cAMP or 2 µM FL-MTX) was 
added and incubated for another 45 minutes at room temperature. For experiments with high 
potassium, KCl concentration in the marine teleost saline buffer was increased 10fold, NaCl 
was isoionic decreased. Tissue was preincubated in high K+-buffer and after 30 minutes the 
fluorescent compound was added as described above. After incubation tissue was viewed by 
means of an inverted confocal laserscanning microscope. 
Images were taken from 10 different tubules and quantified using NIH Scion Image Software 
as described in Breen et al., 2004. Fluorescence levels in epithelial cells and lumens were 
analyzed after background substraction. The diagrammed results are representatives of at least 
two different experiments. 
 
3.5.3 Transport Studies in Rat and Dogfish Shark Choroid Plexus 
Pieces of CP were incubated for 30 min in buffer or buffer with various inhibitors of organic 
anion transport. Then we incubated 90 min (rat) or 60 min (shark) with TR (control) or TR 
with inhibitors added. Substances were diluted in pregassed aCSF or ER, respectively. Stock 
solutions were prepared in water or DMSO, the final DMSO concentration was ≤0.05%. 
Plexuses were gassed with 95% O2/5% CO2 (rat)
 
or 99% O2/1% CO2 (shark) in Ziplock bags 
under slightly positive pressure. Experiments were carried out at room temperature. For some 
experiments a modified aCSF (ER) was used: a) for low Na+ aCSF (ER) NaCl was replaced 
by N-methyl-D-glucamine, b) for Na+-free aCSF (ER) NaCl was replaced by N-methyl-D-
glucamine and NaHCO3 was replaced by choline bicarbonate and c) for high K
+
 aCSF (ER) 
KCl concentration was increased to 47 mM (NaCl was isoionic decreased).  
To aquire images, tissue and incubation solution were transferred to covered teflon chambers 
with a glass coverslip bottom. Chambers were fixed on the stage of a leica DM IRBE or an 
Olympus Fluoview inverted confocal laser scanning microscope. Samples were viewed 
through transmitted light, a x 63 oil immersion objective, a 544 nm HeNe ion laser excitation 
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and a 488/544/633 nm triple dichroic filter. Photomultiplier (PMT) gain was set to yield an 
average fluorescence intensity, with tissue autofluorescence being undetectable. From each 
piece of CP at least 5 images were taken. 
Fluorescence intensity was quantified using the NIH Scion Image software (Breen et al., 
2002). Fluorescence levels in vascular/subepithelial spaces, the interior of blood vessels and 
epithelial cells were analyzed after background substraction from 10 images. All presented 
values are representatives of at least two different experiments. 
 
3.6 Statistics 
All values presented are means +/- SEM. Values of control and treated groups were compared 
with one-way ANOVA test and Dunetts Post test. For P>0.05 no statistical difference was 
observed. Differences were statistically significant for *P<0.05, very significant for **P<0.01 
and extremely significant for ***P<0.001. For statistical analyses Graphpad Prism 4 or Prism 
3.0 software was used. 
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4 Results 
In the present study we investigated into transport processes for organic anions in killifish 
proximal tubules, membrane vesicles of transfected cells and choroid plexus (CP) tissue. To 
study transport mediated by multidrug resistance-asociated protein (Mrp) 4 we used the 
fluorescent compound fluo-cAMP. Before Mrp4 studies could be performed, expression and 
localization of the protein in rat CP tissue and killifish proximal tubules was analyzed. 
 
4.1 Molecular Analyses 
Using RT-PCR and indirect immunohistological staining, Mrp4 expression and localization 
could be demonstrated as described in the following chapters. 
 
4.1.1 Mrp4 Gene Expression in Rat Choroid Plexus 
To analyze Mrp4 gene expression in rat CP, RNA expression levels of Mrp4 and the 
pseudogene free and non-regulated housekeeping gene Porphobilinogen deaminase (Pbgd) 
were compared in rat. For semiquantitative analyses linearity of PCR products was initially 
examined in rat CP. Different cycle numbers were tested and density of bands was measured 
as described in materials and methods. As shown in Figure 8, density of bands accumulated 
with increasing numbers of cycles and than remained static. In Figure 8 A linearity analyses 
of Pbgd are shown, a plateau of band density was reached after 45 cycles. Figure 8 B shows 
analyses of Mrp4, for Mrp4 the plateau was reached after 40 cycles.  
To compare Mrp4 gene expression in rat CP with gene expression of the housekeeping gene, 
a cycle number in the linear area was chosen. For Mrp4 we used 35 cycles as well as for 
Pbgd, at an annealing temperature of 53°C. In Figure 9 PCR products are shown using 
specific primers for Mrp4 and PBGD, respectively. For the PCR product of Pbgd product size 
is 360 bp, PCR of Mrp 4 results in a product of 773 bp. Mrp4 mRNA expression was high in 
rat CP, band density of the PCR product for Mrp4 was comparable to that of Pbgd. 
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Figure 8: Density of bands of PCR products for Pbgd and Mrp4. Density was analyzed using the NIH software 
Scion Image. For Pbgd the linear area started at 30 cycles and reached plateau after 45 cycles. For Mrp4 PCR 
product linearity was reached after 30 cycles with a plateau after 40 cycles. For semiquantitative PCR analyses 
35 cycles were used for Pbgd as well as for Mrp4. 
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Figure 9: mRNA expression of Mrp4 compared to Pbgd in rat CP. PCR product size for Pbgd is 360 bp and for 
Mrp4 is 773 bp. Mrp4 mRNA expression was high in rat CP 
 
 
4.1.2 Immunostaining in Choroid Plexus and Proximal Tubulus 
Following gene expression studies we examined localization of Mrp4 protein in rat CP. It is 
known that Mrp1 and Oatp2 are located to the basolateral, blood facing, membrane of rat CP 
epithelium, whereas Oatp3 and Oat3 are located to the apical membrane. Here, we show 
basolateral localization of Mrp4 in rat CP epithelial cells using indirect immunohistochemical 
analyses.  
In Figure 10 A a control CP is shown. CP tissue was incubated with propidium iodide (PI) 
and secondary FITC-labeled antibody, only nuclei are stained with PI. Figure 10 B shows CP 
tissue after incubation with the specific Mab to MRP4 M4I-80 antibody, rabbit derived FITC-
labeled anti-rat IgG and PI. The green staining is specific for Mrp4 and located to the 
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800 
 Results 
  35 
basolateral membrane of rat CP epithelium. Contemplating that, Mrp4 is colocalized to Mrp1 
to the basolateral membrane of CP epithelial cells in rat. Thus, our results are in accordance 
with Leggas et al. (2004), who described a basolateral localization for Mrp4 in rat CP as well. 
Figure 10: Indirect immunostaining of rat CP. In A a control CP is shown; only nuclei are stained with 
propidium iodide. B shows a CP after staining with the specific Mrp4 antibody and FITC-labeled anti-rat IgG. 
Basolateral staining of Mrp4 can be recognized. 
A B 
  
 
Figure 11: In killifish proximal tubules Mrp4 localisation was proved by indirect immunostaining. A tubulus 
stained with primary pAb rM4-pl antibody and the fluorescein-labeled secondary anti-rabbit IgG 488 antibody is 
shown. Mrp4 is clearly located to the luminal site of proximal tubules epithelial cells. 
 
In a comparative study we examined localization of Mrp4 in killifish (fundulus heteroclitus) 
proximal tubules. Killifish represent an excellent model tissue, since most of its membrane 
transporters are expressed in analogy to mammalian tissue ( Pritchard and Miller, 1991).  
We found luminal localization of the teleost fish analog to Mrp4 (Figure 11) in killifish 
proximal tubules using the specific pAb rM4-pl antibody and indirect staining with 
Apical 
Membrane Basolateral 
Membrane 
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fluorescein-labeled anti-rabbit IgG 488. Mrp2 is located to the luminal site of proximal 
tubulus epithelial cells as well (Masereeuw et al., 2000).  
 
4.2 Functional Analyses 
Functional analyses were carried out using membrane vesicles of MDCKII-MRP2 and Sf9-
MRP4 cells, killifish renal proximal tubules and rat or dogfish shark CP. We used different 
fluorescent dyes as substrates, one of them was the fluorescent cAMP analog 8-[[2-
[(fluoresceinylthioureido)amino]ethyl]thio]-cAMP (fluo-cAMP), which has a molecular 
weight of 815.7 Da (Figure 12 A). Schwede et al. (2000) tested binding of cAMP analogs, 
substituted at position 8 of the adenine moiety (C8), to the cAMP interaction sites of the 
regulatory subunits of cAMP dependent proteinkinase in comparison to cAMP. Fluo-cAMP is 
a lipophylic compound which has the bulkiest substituent of the tested cAMP analogs: 
fluorescein coupled to C8 via a six-atom-spacer. But even with this bulky substituent, fluo-
cAMP was able to bind on two of the binding sites of cAMP dependent proteinkinase, 
indicating that features of the cAMP molecule are conserved.  
Another fluorescent substance used for functional analyses was the fluorescent methotrexate 
analog FL-MTX with a molecular weight of 979.1 Da (Figure 12 B). Transport of fluo-cAMP 
and FL-MTX was compared to transport of the small-sized molecule FL (332.3 Da) (Figure 
12 C) and the medium-sized organic anion TR (625 Da) (Figure 12 D). Different transport 
characteristics were found for all tested dyes. 
Figure 12: Molecular structures of the fluorescent dyes fluo-cAMP (A), FL-MTX (B), FL (C) and TR (D).  
A 
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Figure 12: Molecular structures of the fluorescent dyes fluo-cAMP (A), FL-MTX (B), FL (C) and TR (D). 
B 
 
C 
 
D 
 
 
4.2.1 Transport Studies in Killifish Proximal Tubulus 
Transport studies analyzing transport of the fluorescent cAMP analog fluo-cAMP were 
carried out using freshly isolated killifish kidney proximal tubules. cAMP is a Mrp4 substrate 
(Chen et al., 2001;Van Aubel et al., 2002) and in transport studies we wanted to examine if 
the fluorescent analog is transported by Mrp4 as well.  
Killifish kidneys contain a high fraction of proximal tubules (Physiology of Fishes, 1997), 
which can easily be isolated and are stable for a long period of time at room temperature. 
Furthermore, transport mechanisms in killifish proximal tubules seem to be similar to those in 
mammalians to a large extent (Pritchard and Miller, 1991). Massereeuw, Notenboom and 
Miller researched into transport processes and their regulation in killifish proximal tubules 
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before. Especially transport processes mediated by Mrp2 were analyzed. As shown at page 34 
Mrp4 is located to the luminal membrane of killifish proximal tubules as well as Mrp2, 
therefore we can use this model to investigate into transport of fluo-cAMP, presumably 
mediated by Mrp4. 
Figure 13: Time course of fluo-cAMP transport from bath into proximal tubular lumen. Luminal fluorescence 
reached steady state after 25 minutes, cellular fluorescence was the same for the whole period of time. Luminal 
fluorescence exceeded cellular fluorescence by a factor 5-8. Data are expressed as mean ± SE of 10 tubules from 
one representative isolation. 
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Figure 13 shows the time course of fluo-cAMP transport in killifish proximal tubules. 
Luminal fluorescence increased rapidly over the first 20 min, steady state was reached within 
25 min, thus, subsequent experiments were carried out using incubation times of 45 minutes. 
At steady state luminal fluorescence exceeded cellular fluorescence by a factor 5-8. Cellular 
fluorescence was almost the same for the whole period of time. Fluorescence levels were 
highest in lumens of killifish proximal tubules, followed by epithelial cells. Bath fluorescence 
was the lowest. The high luminal fluorescence accumulation is a strong indication for an 
active, concentrative transport process in killifish proximal tubules. The distribution of fluo-
cAMP with highest levels in lumen and lowest levels in the bath indicates a two-step 
mechanism composed of uptake from the bath at the basolateral membrane of proximal 
tubules epithelial cells and efflux into urine at the apical site. 
Fluo-cAMP excretion into proximal tubular lumens was inhibited by addition of NaCN at a 
concentration of 1 mM. This result indicates a metabolism driven excretion of fluo-cAMP in 
killifish proximal tubules. Inhibition by metabolic poisons is typical for active transport 
processes (Figure 14). 
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Figure 14: Effects of NaCN on fluo-cAMP transport in killifish proximal tubules. Fluo-cAMP transport was 
clearly inhibited after NaCN treatment, luminal and cellular fluorescence were reduced. Data are expressed as 
mean ± SE of 10 tubules from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001). 
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Figure 15 shows the basic characteristics of fluo-cAMP transport in killifish proximal tubules 
at steady state. High fluorescence intensity is recognizable in proximal tubular lumens, 
fluorescence in epithelial cells is lower and background fluorescence is the lowest. 
Figure 15: Fluo-cAMP transport in killifish proximal tubules. Fluo-cAMP accumulated in tubular lumen and to 
a lower extent in epithelial cells, bath fluorescence was very low. 
 
Figure 16 shows a proximal tubulus after treatment with the acyclic adenine derivative 9-(2-
phosphonyl-methoxyethyl)adenine (PMEA, adefovir), which is a known substrate of Mrp4 
(Dallas et al., 2004), at a concentration of 10 µM. Compared to the proximal tubulus shown in 
Figure 15, luminal fluorescence was clearly decreased. As shown below, adefovir treatment 
also affected cellular fluorescence at higher concentrations. 
This known Mrp4 substrate was used at different concentrations to examine its effects on 
fluo-cAMP transport in killifish proximal tubules. After concomitant incubation with 
adefovir, fluo-cAMP accumulation was clearly affected. Luminal and cellular fluorescence 
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intensities were decreased when PMEA was used at concentrations between 1 and 10 µM, a 
dose dependent effect on fluo-cAMP accumulation could be recognized. Contrary to this 
result, accumulation of FL-MTX, a Mrp2 substrate, was not affected by treatment with PMEA 
at the same concentrations (Figure 17). 
Figure 16: A killifish proximal tubulus after incubation with fluo-cAMP and adefovir at a concentration of 10 
µM. Luminal fluorescence is clearly decreased compared to the control tubulus shown in Figure 15. 
 
 
Figure 17: Effects of adefovir on fluo-cAMP and FL-MTX transport in killifish proximal tubules. Adefovir had 
a strong inhibitory effect on fluo-cAMP transport, FL-MTX transport was not affected. Data are expressed as 
mean ± SE of 10 tubules from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001). 
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Incubation with another Mrp4 substrate, azidothymidine (AZT), led to similar effects. Fluo-
cAMP transport was clearly inhibited at concentrations of 50 and 100 µM, luminal 
fluorescence was stronger decreased than cellular fluorescence. FL-MTX transport was not 
affected at the same concentrations (Figure 18). 
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Figure 18: Effects of AZT treatment on fluo-cAMP and FL-MTX transport in killifish proximal tubules. AZT 
treatment reduced luminal acuumulation of fluo-cAMP, cellular accumulation was barely affected. AZT had no 
effects on transport of FL-MTX. Data are expressed as mean ± SE of 10 tubules from one representative 
isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Taken together the results obtained using adefovir and AZT as inhibitors give evidence for 
Mrp4 involvement in fluo-cAMP transport in killifish proximal tubules, because transport of 
FL-MTX, which is mediated by Mrp2, was not affected by the used inhibitors. 
Figure 19: The effects on fluo-cAMP transport after incubation with the parent, non fluorescent molecule 
cAMP. A strong, dose-dependent effect was caused by cAMP treatment, assumably a comparative effect. Data 
are expressed as mean ± SE of 10 tubules from one representative isolation. (Significantly different from control 
values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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To investigate the effect of the non fluorescent molecule cAMP on transport of its analog 
fluo-cAMP we incubated tubules simultaneously with increasing concentrations of the parent, 
non fluorescent compound cAMP. A dose-dependent inhibitory effect at concentrations 
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between 1 and 100 µM was the result. We assume a comparative effect of cAMP on fluo-
cAMP transport (Figure 19). 
8-Bromo-cGMP is a stable cGMP analogon, which inhibits a cAMP specific 
phosphodiesterase, causing intracellular cAMP levels to increase. 1 µM of 8-Bromo-cGMP 
decreased luminal fluo-cAMP accumulation (Figure 20) in killifish proximal tubules, 
suggesting high intracellular cAMP levels as cause. 
Figure 20: Effect of 8-Bromo-cGMP on fluo-cAMP transport in killifish proximal tubules. 8-Br-cGMP led to 
reduced luminal fluo-cAMP accumulation. 8-Br-cGMP causes high intracellular cAMP levels by inhibiting a 
cAMP specific phosphodiesterase, suggesting these cAMP levels as cause for the inhibition. Data are expressed 
as mean ± SE of 10 tubules from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001).  
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Figure 21: Effects of dipyridamole on transport of fluo-cAMP, FL-MTX and LY in killifish proximal tubules. 
Dipyridamole affected luminal fluorescence of all mentioned substrates, suggesting dipyridamole as an inhibitor 
of Mrp2 and Mrp4 mediated transport processes. For FL-MTX cellular fluorescence was reduced as well. Data 
are expressed as mean ± SE of 10 tubules from one representative isolation. (Significantly different from control 
values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Dipyridamole is known to be a potent inhibitor of transport processes mediated by Mrp4 (Van 
Aubel et al., 2002). At concentrations of 5-20 µM dipyridamole inhibited fluo-cAMP 
excretion in a dose-dependent manner (Figure 21 A). We also tested the effects of 
dipyridamole treatment on transport of FL-MTX, a Mrp2 substrate, and LY, another substrate 
of Mrp2 and Mrp4. Luminal efflux of FL-MTX and LY was inhibited as well (Figure 21 B). 
Therefore, dipyridamole seems not only to be an inhibitor for Mrp4 mediated transport, but 
also for transport processes mediated by Mrp2. 
The Mrp inhibitor MK571 had a strong inhibitory effect on fluo-cAMP accumulation in 
proximal tubular cells and lumens at 10 and 25 µM (Figure 22), suggesting one or more of the 
Mrps expressed in killifish proximal tubules to be involved in fluo-cAMP transport. 
Figure 22: Effects of the Mrp inhibitor MK571 on fluo-cAMP transport in killifish proximal tubules. Luminal as 
well as cellular accumulation of fluo-cAMP were affected at concentrations of 10 and 25 µM. Data are expressed 
as mean ± SE of 10 tubules from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001). 
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Leukotriene C4 (LTC4) is a known inhibitor of Mrp1, Mrp2, Mrp3 (Russel et al., 2002) and 
Oatp (Li et al., 2000) mediated transport processes. FL-MTX transport in intact killifish 
proximal tubules was decreased in presence of 0.3 µM LTC4 (Gutmann et al., 2000). LTC4 
decreased transport of fluo-cAMP in killifish proximal tubules as well (Figure 23), lumen and 
epithelial cells were affected. Therefore, Mrp1,2,3 or Oatps seem also to be involved in fluo-
cAMP transport in killifish proximal tubules, the strong inhibitory effect on cellular 
fluorescence leads to the suggestion, that the basolateral uptake step is inhibited as well as 
possibly the efflux step at the apical membrane. Thus, involvement of an Oatp in fluo-cAMP 
uptake is likely. 
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Figure 23: LTC4 effect on fluo-cAMP transport in killifish proximal tubules. The effect on luminal fluorescence 
was very strong, cellular fluorescence was affected as well. Data are expressed as mean ± SE of 10 tubules from 
one representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001). 
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This assumption was supported by inhibition experiments using probenecid which affects 
transport processes mediated by Mrps, Oats and Oatps. Probenecid inhibited transport of fluo-
cAMP (Figure 24). This also leads to the suggestion that one or more transport proteins of the 
mentioned transport families are involved in mediation of fluo-cAMP transport in killifish 
proximal tubules. 
Figure 24: Effects of probenecid on fluo-cAMP transport in killifish proximal tubules. Luminal fluo-cAMP 
accumulation was affected at concentrations of 10 and 50 µM, cellular fluorescence was only affected at 50 µM. 
Data are expressed as mean ± SE of 10 tubules from one representative isolation. (Significantly different from 
control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Figure 25: Effect of ES on fluo-cAMP transport in killifish proximal tubules. At 50 µM luminal fluorescence 
was clearly reduced, changes in cellular accumulation were not statistically significant. Data are expressed as 
mean ± SE of 10 tubules from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001). 
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Estrone sulfate (ES) is a substrate for Oats, Oatps and Mrps. Incubation with fluo-cAMP and 
ES led to a significant decrease of luminal fluorescence intensity at 20 and 50 µM (Figure 
25). Oats, Oatps or Mrps seem to play a role in transport of the fluorescent compound fluo-
cAMP in killifish proximal tubules. 
Figure 26: Effect of PAH on fluo-cAMP transport in killifish proximal tubules. PAH only had an effect at a high 
concentration (1 mM), luminal but not cellular fluorescence was decreased. Data are expressed as mean ± SE of 
10 tubules from one representative isolation. (Significantly different from control values: * for P<0.05, ** for 
P<0.01 and *** for P<0.001). 
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p-Aminohippurate (PAH), a substrate of Oats, Mrp2 and Mrp4 (Smeets et al., 2004), had no 
effect on fluo-cAMP transport in killifish proximal tubules at lower concentrations (10-
50µM). At the higher concentration of 1mM it reduced luminal accumulation of fluo-cAMP, 
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cellular accumulation was not reduced (Figure 26). These results indicate inhibition of the 
efflux step for fluo-cAMP from epithelial cells into lumen at the apical membrane, 
presumably mediated by Mrp4 and Mrp2. 
Figure 27: Effect of increasing medium K+ by an order of magnitude. High K+ levels lead to depolarisation of 
epithelial cells and changes in the electrical potential. This treatment had no effect on fluo-cAMP transport in 
killifish proximal tubules, suggesting independency of fluo-cAMP transport from PD. Data are expressed as 
mean ± SE of 10 tubules from one representative isolation.  
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Figure 28: Effects of the herbicide 2,4-D on fluo-cAMP transport. 2,4-D treatment had no effect on distribution 
of fluo-cAMP within the tissue. Data are expressed as mean ± SE of 10 tubules from one representative 
isolation. 
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At an increased KCl concentration of 47 mM (isotonic NaCl replacement), we found no 
effects on fluo-cAMP accumulation (Figure 27). Increasing K+-levels in the incubation 
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solution lead to depolarisation of epithelial cells. Thus, fluo-cAMP transport in killifish 
proximal tubules seems to be insensitive to changes in electrical potential differences (PD). 
The herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) which is a modulator of Oat3 mediated 
FL transport in rat and shark CP (Breen et al., 2002; Villalobos et al., 2002), had no effect on 
fluo-cAMP transport in killifish proximal tubules (Figure 28). Therefore, fluo-cAMP seems to 
be transported by different transportproteins than FL. 
Since the overlapping substrate specificity of Mrp2 and Mrp4 makes a functional distinction 
of the two transport proteins difficult, further insights into the regulatory pathways may be 
helpful to discriminate their impact on fluo-cAMP transport. Masereeuw et al. (2000) showed 
that organic anion transport in killifish proximal tubules is regulated by an Endothelin (ET) 
pathway signaling through protein kinase C [PKC], starting with the binding of Endothelin 1 
(ET1) to the Endothelin B (ETB) receptor and a subsequent cascade via NO-synthase and 
PKC which ends in a functional downregulation of Mrp2 (Notenboom et al., 2002).  
Figure 29: Effect of ET1 on fluo-cAMP transport in killifish proximal tubules. ET1 had nor an effect on luminal 
neither on cellular accumulation. Data are expressed as mean ± SE of 10 tubules from one representative 
isolation. 
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ET1 has a dose dependent inhibitory effect on transport processes mediated by Mrp2 at 
nanomolar concentrations. As shown in shark rectal gland tubules, luminal accumulation of 
sulforhodamine 101 (Texas Red, TR), another Mrp2 substrate, was decreased by ET1, but it 
had no effect on cellular accumulation of sulforhodamine 101 (Miller et al., 2002). FL-MTX 
excretion into the lumen of killifish proximal tubules was significantly reduced in presence of 
ET1 at nanomolar concentrations. ET1 had no effect on cellular accumulation of FL-MTX 
(Masereeuw et al., 2000).  
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ET1, at 1 and 10 nM, had no effect at all on luminal or cellular accumulation of fluo-cAMP in 
killifish kidney proximal tubules (Figure 29), suggesting the ET signal cascade not to be 
involved in regulation of fluo-cAMP transport in killifish proximal tubules. 
Figure 30: Effect of nitroprusside-Na+ on transport of fluo-cAMP in killifish proximal tubules. The NO-donor 
did not affect distribution of fluo-cAMP. Data are expressed as mean ± SE of 10 tubules from one representative 
isolation. 
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Nitroprusside-Na+ leads to rapid NO release. The NO-donor had no effect on luminal and 
cellular fluo-cAMP accumulation (Figure 30), suggesting that NO release is no crucial factor 
for regulation of fluo-cAMP transport. 
Figure 31: Effect of the phorbol ester PMA on fluo-cAMP transport in killifish proximal tubules. PMA leads to 
activation of PKC, this activation had no effect on fluo-cAMP transport. Data are expressed as mean ± SE of 10 
tubules from one representative isolation. 
0.0 10.0 100.0
0
1000
2000
3000
lumen
cells
PMA in nM
Fl
u
o
re
sc
en
ce
 
ET signaling involves activation of an ET receptor-coupled G protein which in turn activates 
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phospholipase C and PKC. FL-MTX transport into lumen in killifish proximal tubules was 
reduced when PKC was activated. PKC can be activated by phorbol ester. Incubation with 
PMA (phorbol-12-myristate-13-acetate) at 50 nM and 100 nM led to reduced FL-MTX 
accumulation in proximal tubular lumens (Masereeuw et al., 2000). However, in the present 
study, 10 nM and 100 nM PMA had no effects on fluo-cAMP distribution (Figure 31), 
suggesting that this regulatory cascade is of no relevance for transport of fluo-cAMP in 
killifish proximal tubules. 
Soodvilai et al. (2004) investigated regulation of transport mechanisms mediated by Oat3. 
They showed that activation of PKC downregulates the action of Oat3. In contrast, activation 
of PKA leads to upregulation of Oat3 mediated transport.  
To examine if PKA activation increases fluo-cAMP excretion in killifish proximal tubules we 
used the direct PKA activator dibutyryl cAMP (db-cAMP). At the used concentrations 5 µM 
and 25 µM db-cAMP had no effects on fluo-cAMP distribution within the tissue (Figure 32) 
which indicates that activation of PKA is not involved in regulation of fluo-cAMP transport in 
killifish proximal tubules. 
Figure 32: Effect of db-cAMP on transport of fluo-cAMP in killifish proximal tubules. The direct PKA activator 
did not affect fluo-cAMP transport. Data are expressed as mean ± SE of 10 tubules from one representative 
isolation. 
0.0 25.0
0
1000
2000
3000
4000
lumen
cells
db-cAMP in µM
Fl
u
o
re
sc
en
ce
 
We tested another PKA activator which indirectly activates PKA due to an inhibition of 
phosphodiesterase and, subsequently, increasing intracellular cAMP concentration, forskolin. 
Forskolin treatment led to reduced fluo-cAMP transport in killifish proximal tubules in a 
dose-dependent manner at micromolar concentrations. To analyze whether this inhibition is 
caused by PKA activation, the PKA inhibitor H-89 was used concomitantly. We incubated 
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with 1) forskolin 10 µM, 2) H-89 50 nM or 3) forskolin 10 µM and H-89 50 nM. Figure 33 
shows that H-89 decreased fluo-cAMP accumulation, but did not alter the forskolin effect. 
Similar results were found by Miller et al. (2002) in shark rectal gland tubules. We suggest 
that the inhibitory effect caused by forskolin treatment is caused by increased intracellular 
cAMP levels and not by PKA activation, because H-89 could not affect the inhibition caused 
by forskolin treatment. 
Figure 33: Effects of forskolin and H-89 on fluo-cAMP transport in killifish proximal tubules. The indirect PKA 
activator forskolin led to reduced fluorescence levels in the lumen as well as H-89. H-89 could not alter the 
forskolin effect. Data are expressed as mean ± SE of 10 tubules from one representative isolation. (Significantly 
different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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4.2.2 Uptake Studies in Membrane Vesicles 
To approve the presumptions found by analyses of fluo-cAMP transport in killifish proximal 
tubules, we used membrane vesicles of overexpressing MDCKII-MRP2 and Sf9-MRP4 cells 
for specifc uptake studies and found evidences for fluo-cAMP transport mediated by MRP2 
and MRP4. Western Blot studies performed at the NCMLS (Nijmegen, the Netherlands) 
demonstrated presence of the studied transport proteins (data not shown). 
Initially, uptake of the common MRP4 substrate [³H]-cGMP (Van Aubel et al., 2002) was 
analyzed. Uptake of [³H]-cGMP at a concentration of 7 µM into Sf9-MRP4 membrane 
vesicles was a specific transport process that was dependent on ATP hydrolysis (Figure 34). 
As described in materials and methods, we measured uptake of fluo-cAMP into membrane 
vesicles in presence of 5’-AMP or ATP (Figure 34 A). ATP-dependent transport was 
calculated by substracting values obtained in presence of 5’-AMP from those obtained in 
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presence of ATP (Figure 34 B). To calculate MRP2 or MRP4 specific transport, values for 
ATP-dependent transport of control vesicles were substracted from those of transfected cell 
membrane vesicles (Figure 34 C). 
Figure 34: ATP-dependent, specific uptake of [³H]-cGMP by MRP4 into membrane vesicles. In A uptake of 
fluo-cAMP into membrane vesicles in presence of 5’-AMP or ATP is shown. B shows active, ATP-dependent 
transport, in C specific uptake of fluo-cAMP into membrane vesicles mediated by MRP4 is shown. Data are 
expressed as mean ± SE of three samples from one representative experiment. Ops: Opsine (control), Sf9-MRP4 
93: MRP4 vesicles, batch 93. 
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Figure 35: Effects of fluo-cGMP and fluo-cAMP on specific transport of [³H]-cGMP mediated by MRP4. 
Uptake of [³H]-cGMP into membrane vesicles was significantly reduced after fluo-cAMP treatment. Data are 
expressed as mean ± SE from three samples of one representative experiment. 
Sf9
-
MR
P4
Sf9
-
MR
P4
 
flu
o-
cG
MP
Sf9
-
MR
P4
 
flu
o-
cA
MP
0
100
200
300
400
500
600
700
800
900
**
fM
o
l/m
g/
m
in
 
To test whether the fluorescent compounds fluo-cAMP and fluo-cGMP may be substrates for 
human MRP4 expressed in Sf9 cells, their effect on transport of [³H]-cGMP at a concentration 
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of 7 µM in Sf9-MRP4 vesicles was studied. Concentrations of 20 µM fluo-cAMP and fluo-
cGMP were used. Incubation with fluo-cAMP led to significantly reduced uptake of [³H]-
cGMP into Sf9-MRP4 vesicles, whereas the effect of fluo-cGMP was not statistically 
significant (Figure 35). 
Further investigations regarded fluo-cAMP uptake into Sf9-MRP4 membrane vesicles. Fluo-
cAMP uptake into Sf9-MRP4 vesicles was specific and ATP-dependent as shown in Figure 
36 for 50 and 100 µM fluo-cAMP. At these concentrations fluo-cAMP transport by MRP4 
seems to be saturated, no differences between transport rates were obtained. 
Figure 36: Fluo-cAMP uptake into Sf9-MRP4 membrane vesicles was a ATP-dependent, specific transport 
process. At 50 and 100 µM fluo-cAMP no differences of transport rates were obtained. In A active transport of 
fluo-cAMP in control (Ops) and MRP4 membrane vesicles is shown. B shows specific uptake of fluo-cAMP 
mediated by MRP4. Data are expressed as mean ± SE of three samples from one representative experiment. 
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Characteristics of fluo-cAMP transport including time and concentration course were studied. 
In Figure 37 the time course of fluo-cAMP into Sf9-MRP4 membrane vesicles is 
diagrammed. To analyze time course we measured fluorescence levels after different 
incubation times for 20 µM fluo-cAMP. Amount of fluo-cAMP transported by MRP4 in Sf9-
MRP4 membrane vesicles increased for the first 20 minutes and reached steady state after 20-
30 min. To analyze fluo-cAMP transport in the increasing domain, following experiments 
were carried out with incubation times of 10 minutes. 
To analyze kinetics of fluo-cAMP transport by human MRP4 expressed in Sf9 cells, we tested 
fluo-cAMP concentrations between 1 and 25 µM. Fluo-cAMP transport in Sf9-MRP4 vesicles 
was concentration dependent with a Vmax value of 1.1 +/-0.2 nMol/mg/min and an apparent 
Km value of 5.3 +/- 2 µM (Figure 38). 
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Figure 37: Time course of fluo-cAMP (20 µM) uptake mediated by MRP4 expressed in Sf9 cells. Accomodated 
fluo-cAMP amount per milligramm protein increased for the first 20 minutes and than reached steady state. Data 
are expressed as mean ± SE from 3 independent experiments. MRP4 94-: batch 94-. 
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Figure 38: Concentration course of fluo-cAMP uptake into Sf9-MRP4 membrane vesicles. Fluo-cAMP transport 
was concentration dependent and saturable with a Vmax of 1.1 +/-0.2 nMol/mg/min and an apparent Km value 
of 5.3 +/- 2 µM. Data are expressed as mean ± SE from 3 independent experiments. MRP4 94-: batch 94-. 
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To test whether fluo-cAMP is transported by human MRP2 as well, we investigated into fluo-
cAMP transport in MDCKII-MRP2 vesicles. Uptake into membrane vesicles mediated by 
MRP2 was a ATP-dependent, specific transport process as shown in Figure 39. Transport rate 
was 0.503 nMol/mg/min for fluo-cAMP transport at a concentration of 20 µM.  
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Figure 39: ATP-dependent, specific transport of fluo-cAMP 20 µM into MDCKII-MRP2 membrane vesicles. 
Fluo-cAMP was transported by a rate of 0.503 nMol/mg/min. In A active transport processes are shown in 
control (MDCKII) and MRP2 membrane vesicles. B shows specific uptake of fluo-cAMP mediated by MRP2. 
Data are expressed as mean ± SE of three samples from one representative experiment. 
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To research into transport characteristics for fluo-cAMP uptake by MRP2 in MDCKII-MRP2 
vesicles, time and concentration dependency were analyzed. At a concentration of 20 µM 
fluo-cAMP transport reached steady state after 10-20 minutes (Figure 40). 
Figure 40: Fluo-cAMP transport into MDCKII-MRP2 membrane vesicles reached steady state after 10-20 
minutes incubation with fluo-cAMP at 20 µM. Data are expressed as mean ± SE from 3 independent 
experiments. 
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For further experiments we used incubation times of 5 minutes. An apparent Km value of 4.8 
+/-1.5 µM was determined for ATP-dependent transport of fluo-cAMP mediated by MRP2 
expressed in MDCKII cells. The Vmax value was 7.2 +/- 0.6 nMol/mg/min (Figure 41). 
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Figure 41: Concentration course of fluo-cAMP uptake into MDCKII-MRP2 membrane vesicles. The apparent 
Km was 4.8 +/-1,5 µM with a Vmax value of 7.2 +/- 0.6 nMol/mg/min. Data are expressed as mean ± SE from 3 
independent experiments. 
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Taken together, these results indicate that affinities of fluo-cAMP to MRP4 (5.3 +/- 2 µM) 
and MRP2 (4.8 +/-1,5 µM) are not statistically different. Maximum speed was 7-fold higher 
for transport mediated by MRP2, but due to the different expression system and expression 
rate, this value is of no relevance. 
 
4.2.3 Transport Studies in Rat and Shark Choroid Plexus 
 
4.2.3.1 Fluo-cAMP Transport in Rat Choroid Plexus 
Different substances and their transport characteristics were investigated in rat and dogfish 
shark CP. Transport of the fluorescent compound fluo-cAMP was analyzed in rat CP and 
results were compared to results obtained from transport studies in killifish renal proximal 
tubules and Sf9-MRP4 and MDCKII-MRP2 membrane vesicles.  
In Figure 42 basic characteristics of fluo-cAMP transport (2 µM) in intact rat CP are shown. 
Steady state fluorescence in vascular/perivascular spaces and in the interior of blood vessels 
was much higher than in epithelial cells. Cellular fluorescence levels were higher than 
fluorescence levels in the bath, but fluorescence levels in the bath were quite high compared 
to bath fluorescence obtained using different fluorescent compounds or fluo-cAMP 
distribution in killifish proximal tubules. Accumulation of fluo-cAMP in 
vascular/perivascular spaces and in the interior of blood vessels indicate an active transport 
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process, allocation of fluorescence levels between lumen, epithelial cells and bath are a sign 
of an active two-step mechanism. 
Figure 42: Basic characteristics of fluo-cAMP (2 µM) transport in rat CP. Fluo-cAMP accumulated in 
perivascular/subepithelial spaces and the interior of the blood vessel and to a lower extent in epithelial cells. 
Cellular fluorescence barely exceeded cellular fluorescence. In the blood vessel an area of low fluorescence can 
be recognized where red blood cells are located. 
 
To learn more about characteristics of fluo-cAMP transport in rat CP and transport proteins 
involved, different inhibitors of organic anion transport were added and their effects were 
measured. 
Figure 43: Effect of methotrexate on fluo-cAMP transport (2 µM) in rat CP. Compared to the control CP in 
Figure 42 fluorescence levels were clearly decreased after incubation with methotrexate. 
 
In Figure 43 the effect of methotrexate (200 µM) on fluo-cAMP transport is pictured, to show 
an exemplary effect of an inhibitor of organic anion transport. In comparison to Figure 42, 
fluo-cAMP accumulation is clearly affected by methotrexate treatment. 
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In Figure 44 the time course of fluo-cAMP accumulation in vascular/subepithelial spaces, the 
interior of blood vessels and epithelial cells in rat CP is shown. Steady state was reached after 
75 minutes. Cellular fluorescence was approximately 40% of luminal fluorescence, bath 
fluorescence was relatively high. Further experiments were carried out using incubation times 
of 90 minutes. 
Figure 44: Time course of fluo-cAMP transport in rat CP. Steady state was reached after 75 minutes with 
cellular fluorescence being ~ 40% of luminal fluorescence. Data are expressed as mean ± SE of 10 CP blood 
vessels from one representative isolation. 
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Fluo-cAMP accumulation in vascular/perivascular spaces and the interior of blood vessels as 
well as in epithelial cells was saturated using increasing concentrations of fluo-cAMP. 
Concentrations between 1 and 10 µM were used. At concentrations > 2 µM luminal and 
cellular saturations were reached (Figure 45). All other experiments were carried out using a 
concentration of 2 µM fluo cAMP. 
Figure 45: Concentration course of fluo-cAMP transport in rat CP. Saturation was reached at concentrations > 2 
µM. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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Fluo-cAMP transport is Na+-dependent as shown in Figure 46. Fluorescence levels in lumen 
and epithelial cells were decreased after incubation with Na+-free aCSF. Concominant 
reduction of luminal und cellular fluorescence indicates inhibition of uptake at the apical 
membrane of rat CP epithelium. A Na+-dependent uptake transporter seems to be involved in 
fluo-cAMP uptake into CP epithelial cells. 
Membrane depolarisation accomplished by increasing K+ concentration 10 fold had no effect 
on fluo-cAMP transport in rat CP (Figure 46). Therefore fluo-cAMP transport in rat CP seems 
to be insensitive from changes in membrane potential. 
Figure 46: Effects of incubation with Na+-free and high K+ aCSF on fluo-cAMP transport in rat CP. Removing 
Na+ had a strong inhibitory effect on fluo-cAMP accumulation in vascular/perivascular spaces, the interior of 
blood vessels and epithelial cells. Increasing K+ tenfold did not affect fluo-cAMP transport. Data are expressed 
as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly different from control 
values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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The inhibitory effect obtained using the metabolic poison NaCN indicates a metabolism 
driven transport of fluo-cAMP in rat CP. But NaCN treatment only affected luminal fluo-
cAMP accumulation (Figure 47). Metabolism driven transport is characteristic for active 
transport processes. 
To figure out which transport proteins are involved in fluo-cAMP transport in rat CP different 
specific inhibitors were used. LTC4 had an inhibitory effect on luminal fluo-cAMP 
accumulation, but not on cellular accumulation (Figure 47), suggesting inhibiton of one or 
more basolateral efflux transporters. 
 
 
 
 Results 
  59 
Figure 47: Effects of LTC4 and NaCN on fluo-cAMP transport in rat CP. Both substances only affected luminal 
fluorescence, epithelial cell fluorescence was not concerned. Data are expressed as mean ± SE of 10 CP blood 
vessels from one representative isolation. (Significantly different from control values: * for P<0.05, ** for 
P<0.01 and *** for P<0.001). 
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Methotrexate is a substrate for different Mrps. Inhibition of fluo-cAMP transport caused by 
methotrexate treatment is an evidence for involvement of one or more Mrps in mediation of 
fluo-cAMP transport in rat CP. The effect of methotrexate addition at different micromolar 
concentrations is diagrammed in Figure 48. Only luminal accumulation of fluo-cAMP was 
affected by methotrexate at concentrations between 100 and 400 µM.  
Figure 48: Effects of methotrexate on fluo-cAMP transport in intact rat CP. Methotrexate had a strong inhibitory 
effect on basolateral efflux of fluo-cAMP. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001). 
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MK 571, a potent inhibitor of Mrp mediated transport processes, led to reduced fluorescence 
levels in vascular/perivascular spaces, the interior of blood vessels and, at a higher 
concentration, also in epithelial cells. These effects were dose dependent (Figure 49). The 
effects indicate involvement of one or more Mrps in fluo-cAMP transport in rat CP. 
Figure 49: Effects of MK571 on fluo-cAMP transport in rat CP. At 10 µM only luminal fluorescence was 
affected, at a higher concentration cellular fluorescence was decreased as well. Data are expressed as mean ± SE 
of 10 CP blood vessels from one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001).  
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Figure 50: Effects of adefovir on fluo-cAMP transport. Adefovir had no effect on fluo-cAMP accumulation 
within the tissue at concentrations betweeen 1 and 10 µM. Data are expressed as mean ± SE of 10 CP blood 
vessels from one representative isolation. 
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To detect which transport proteins of the Mrp family are involved in mediation of fluo-cAMP 
transport in rat CP, different Mrp4 substrates were tested. Adefovir did not affect fluo-cAMP 
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transport in rat CP at the same concentrations (1-10 µM) we used in killifish proximal tubules 
(Figure 50). We tested higher concentrations as well, but even at a concentration of 500 µM 
adefovir did not affect fluo-cAMP transport in rat CP (Figure 51). 
Figure 51: Effects of adefovir on fluo-cAMP transport in rat CP. Even at concentrations up to 500 µM adefovir 
did not effect distribution of fluo-cAMP. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. 
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The cyclic nucleotides cAMP and cGMP are known substrates of Mrp4 (Van Aubel et al., 
2002). Both were used at high micromolar concentrations, but no effects on fluo-cAMP 
transport were obtained (Figure 52). Interestingly even the unlabeled cAMP had no effect on 
transport of its fluorescent analog. In rat CP cAMP and fluo-cAMP seem to be transported by 
different transport proteins. 
Figure 52: Effects of the cyclic nucleotides cAMP and cGMP on fluo-cAMP transport in rat CP. Neither cAMP 
nor cGMP had any effects on fluo-cAMP transport at high concentrations up to 500 or 1000 µM. Data are 
expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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Prostaglandin E2 (PGE2) is known as Mrp4 substrate as well (Reid et al., 2003). It had no 
effect on fluo-cAMP accumulation within vascular/perivascular spaces and the interior of 
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blood vessels. Epithelial cell fluorescence was affected, but only at a concentration of 1 µM 
and not at 5 µM of PGE2 (Figure 53), suggesting an unspecific effect. 
Figure 53: Effects of PGE2 on fluo-cAMP transport in rat CP. PGE2 did not affect luminal accumulation but 
reduced cellular fluorescence at a concentration of 1 µM. Data are expressed as mean ± SE of 10 CP blood 
vessels from one representative isolation.  
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Summarizing the effects of adefovir, the cyclic nucleotides cAMP and cGMP and PGE2, 
involvement of Mrp4 in fluo-cAMP efflux at the basolateral membrane of CP epithelial cells 
can be ruled out. 
Mrp2 expression is low in rat CP, analyzed by Choudhuri et al. (2003) on RNA level. To 
exclude an involvement of Mrp2 on fluo-cAMP transport, TR- rats were used. TR- rats are 
wistar rats, deficient of Mrp2. The TR- or GY rats were first established in Groningen (the 
Netherlands). Those Mrp2-deficient Groningen Yellow/Transport deficient wistar rats have a 
Mrp2 deformity. In TR- rats mRNA levels of Mrp2 are very low and the protein is absent. 
This is due to a single nucleotide deletion in the gene resulting in a frame shift, which leads to 
an early stop codon. A human analog to TR- rats is the Dubin-Johnson syndrome patient. 
Dubin-Johnson patients are lacking MRP2 causing a defiency in the biliary excretion of 
several glutathione conjugates, glucuronides and other MRP2 substrates (Masereeuw et al., 
2003). 
Fluo-cAMP transport in TR- rats was compared with its transport in wistar wildtype rats. No 
differences were obtained for the different rat strains (Figure 54). This means that Mrp2 is not 
involved in fluo-cAMP transport in rat CP. 
Incubation with probenecid at 10-100 µM led to reduced fluorescence levels in 
vascular/perivascular spaces, the interior of blood vessels and CP epithelial cells. 10 µM did 
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not affect fluo-cAMP transport in rat CP, but the higher concentrations did. Cellular 
fluorescence was only affected by probenecid at the highest used concentration of 100 µM 
(Figure 55). These effects allude participation of Mrps different from Mrp2 and Mrp4, Oatps 
or Oats in fluo-cAMP transport in rat CP. 
Figure 54: Fluo-cAMP transport in CP of wistar rats as control or TR- rats. No differences in luminal or cellular 
fluorescence were obtained. Data are expressed as mean ± SE of 10 CP blood vessels from one representative 
isolation. 
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Figure 55: Effects of probenecid on fluo-cAMP transport in rat CP. Luminal fluorescence was affected by 
probenecid at a concentration of 50 and 100 µM, cellular fluorescence was only reduced at 100 µM. Data are 
expressed as mean ± SE of 10 CP blood vessels from one representative isolation. 
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Na+-taurocholate, a substrate for Oats and Oatps (Miller, 2004), was used at concentrations 
between 10 and 100 µM. The result was a dose-dependent inhibitory effect on luminal and, at 
100 µM, cellular fluo-cAMP accumulation. The inhibitory effect was strong and reduced 
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luminal and cellular fluorescence levels below background fluorescence at 100 µM (Figure 
56). This is evidence for an Oat or Oatp involved in fluo-cAMP transport in rat CP. 
Figure 56: Effects of Na+-taurocholate on fluo-cAMP transport in rat CP. Luminal and cellular fluorescence 
were decreased by Na+-taurocholate treatment in a dose-dependent manner. Data are expressed as mean ± SE of 
10 CP blood vessels from one representative isolation. (Significantly different from control values: * for P<0.05, 
** for P<0.01 and *** for P<0.001). 
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Figure 57: Effects of digoxin on fluo-cAMP transport in rat CP. Digoxin did not affect luminal or cellular 
fluorescence at concentrations between 10 and 500 µM. Data are expressed as mean ± SE of 10 CP blood vessels 
from one representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and 
*** for P<0.001). 
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To examine whether the exchanger Oatp2, which is located to the basolateral membrane of 
CP epithelium (Kusuhara et al., 2004), is involved in fluo-cAMP transport in rat CP, digoxin 
was used. The cardiac glykoside digoxin has a higher affinity to Oatp2 than to the other 
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members of the Oatp family (Kusuhara et al., 2004). Digoxin had no effect on distribution of 
fluo-cAMP within CP tissue, even though high concentrations up to 500 µM digoxin were 
used (Figure 57). Therefore Oatp2 seems not to be involved in active efflux of fluo-cAMP on 
the basolateral membrane of CP epithelium in rats. 
Na+-dependency indicates involvement of an Oat, because transport processes mediated by 
Oats are affected by changes in Na+ concentration. rOat3 is the most abundant isoform 
expressed in CP epithelium and located to the apical membrane (Miller, 2004). rOat1 is only 
expressed to a lower extent in rat CP. This transporter could only be detected at mRNA level 
and protein expression could not be demonstrated (Kusuhara et al., 2004).  
PAH, used at concentrations up to 4 mM, did not affect fluo-cAMP distribution in rat CP 
(Figure 58). Since PAH is an inhibitor of Oat1 and Oat3, the results obtained after incubation 
with PAH lead to the assumption that rOat1 and rOat3 seem not to be transporter involved in 
fluo-cAMP uptake at the apical membrane of epithelial cells. As PAH is a low affinity 
substrate for Mrp2 and Mrp4 as well, this result is one more evidence for mediation of fluo-
cAMP transport independent from Mrp2 and Mrp4. 
Figure 58: Effects of PAH on fluo-cAMP transport in rat CP. PAH at concentrations between 0.1 and 4 mM had 
no effects on fluo-cAMP transport. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation.  
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2,4-D, a substance that has an inhibitory effect on Oat3 mediated transport of FL in rat CP 
(Breen et al., 2002), had no effects on fluo-cAMP transport (Figure 59). Fluo-cAMP transport 
seems to be mediated by transport proteins beeing different from those involved in FL 
transport in rat CP. 
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Figure 59: Effects of 2,4-D on fluo-cAMP transport in rat CP. 2,4-D affected fluo-cAMP transport only 
unspecific, at a concentration of 50 µM cellular fluorescence was increased. At concentrations between 5 and 
500 µM no other effect was obtained. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001).  
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To examine regulatory processes controlling fluo-cAMP transport in rat CP we investigated 
into different pathways. Initially, an endothelin pathway was studied.  
Figure 60: Effects of ET1 on fluo-cAMP transport in rat CP. ET1 had no effect at all on fluo-cAMP 
accumulation in vascular/perivascular spaces, the interior of blood vessels or epithelial cells. Data are expressed 
as mean ± SE of 10 CP blood vessels from one representative isolation. 
0.0 1.0 10.0 100.0
0
50
100
150
200 lumen
cells
ET1 in nM
Fl
u
o
re
sc
en
ce
 
ET1 binding on ETB receptor leads to a subsequent cascade via NO-synthase and activation of 
PKC. To research into this cascade we incubated rat CP with ET1 at nanomolar 
concentrations and fluo-cAMP. ET1 treatment did not affect fluo-cAMP transport in rat CP 
(Figure 60). This result leads to the suggestion that no ET pathway is involved in regulation 
of fluo-cAMP transport in rat CP. 
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To analyze whether PKC, activated by a different cascade than via ET1 signaling, is involved 
in regulation of fluo-cAMP transport, the phorbol ester phorbol-12-myristate-13-acetate 
(PMA) was used. PMA had no effects on fluorescence intensities in vascular/perivascular 
spaces, the interior of blood vessels or epithelial cells in rat CP as shown in Figure 61. 
Therefore, ET1 and PKC seem not to be involved in regulatory processes concerning fluo-
cAMP transport in rat CP. 
Figure 61: Effects of the phorbol ester PMA on fluo-cAMP transport in rat CP. PMA did not affect luminal or 
cellular fluorescence. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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To verify whether activation of PKA affects fluo-cAMP transport in rat CP, the indirect PKA 
activator forskolin was added. We incubated tissue with forskolin and H-89 as described 
above. Forskolin had no effect on fluo-cAMP transport at micromolar concentrations, nor had 
the PKA inhibitor H-89 (Figure 62). 
Another pathway which may be involved in regulation of fluo-cAMP transport in rat CP is the 
mitogen-activated protein kinase (MAPK) pathway. Epidermal growth factor (EGF) leads to 
phosphorylation of mitogen-activated/extracellular signal-regulated kinase (MEK), 
extracellular signal-regulated kinase 1 and 2 (ERK1/2) and phospholipase A2 (PLA2). PLA2 
activation leads to increased release of arachidonic acid which is metabolised to prostaglandin 
via cyclooxygenase 1 (COX1). Prostaglandin leads to PKA activation via adenylate cyclase 
activation (Soodvilai et al., 2004). 
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Figure 62: Effects of forskolin and H-89 on fluo-cAMP transport in rat CP. Neither the PKA activator forskolin 
nor the PKA inhibitor H-89 affected distribution of fluo-cAMP in vascular/perivascular spaces, the interior of 
blood vessels and epithelial cells. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. 
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Figure 63: Effects of U0126 on fluo-cAMP transport in rat CP. U0126 had a strong inhibitory effect on cellular 
fluorescence, fluorescence in vascular/perivascular spaces and the interior of blood vessels were only affected at 
concentrations of 10 and 50 µM. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001).  
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Effects provoked by the MEK1/2 specific inhibitor U0126 were analyzed. U0126 had a strong 
inhibitory effect on fluo-cAMP accumulation in vascular/perivascular spaces, the interior of 
blood vessels and epithelial cells in rat CP at 10 and 50 µM. At 1 µM U0126 only cellular 
fluorescence was reduced (Figure 63). These results indicate an inhibition of apical uptake 
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into CP epithelial cells and hence decreased accumulation of fluo-cAMP in 
vascular/perivascular spaces and the interior of blood vessels. 
EGF activates the MAPK pathway. If this pathway is involved, EGF should alter the 
inhibitory effect triggered by U0126.  
Figure 64: Effects of EGF and U0126 on fluo-cAMP transport in rat CP. EGF had no effect and could not alter 
the inhibitory effect of U0126. Data are expressed as mean ± SE of 10 CP blood vessels from one representative 
isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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We incubated CPs with fluo-cAMP and 1) EGF 100 ng/ml or 2) U0126 10 µM or 3) EGF 100 
ng/ml and U0126 10 µM. EGF alone had no effect, MAPK is not activated. As described 
above U0126 had a strong inhibitory effect which cannot be altered by EGF addition (Figure 
64). The inhibitory effect of U0126 should be altered by EGF in case MAPK pathway was 
involved. But regarding the results obtained from inhibitor studies using EGF and U0126, the 
MAPK pathway seems not to be involved in regulation of fluo-cAMP transport in rat CP. The 
U0126 effect seems to be independent from MAPK pathway activation. 
 
4.2.3.2 [3H]-cGMP transport in rat CP 
As mentioned above cGMP is a known substrate of Mrp4, which we localized to the 
basolateral membrane of rat CP epithelium using indirect immunohistochemistry (Figure 10 
B). To verify this localization, we carried out functional analyses using the radioactive labeled 
compound [³H]-cGMP, which is a specific substrate for Mrp4. Using radioactive compounds 
we can only detect changes in accumulation within whole CP tissue, reflecting inhibition or 
activation of transport processes at the apical membrane of CP epithelium. If Mrp4 is 
localized to the apical membrane of CP epithelium, an inhibition caused by adefovir would 
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lead to increased radioactivity in the tissue. Inhibition of a basolateral localized Mrp4 would 
cause reduced radioactivity in epithelial/subepithelial spaces and the interior of blood vessels, 
cellular fluorescence would be increased, but total radioactivity in CP tissue would remain 
stable.  
For functional analyses CPs were incubated with [³H]-cGMP and the Mrp4 inhibitor adefovir 
at concentrations between 5 and 50 µM. Amount of [³H]-cGMP in the tissue was measured 
afterwards. After incubation with adefovir extent of radioactivity in the tissue was not 
affected significantly in comparison to a control (Figure 65).  
Figure 65: Effects of adefovir on [³H]-cGMP transport in rat CP. No statistically different changes compared to 
control were obtained. Data are expressed as mean ± SE of three independent isolations 
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These findings confirm the localization we detected for Mrp4, because extent of radioactivity 
in the whole tissue was not affected after inhibition of Mrp4.  
 
4.2.3.3 Texas Red Transport in Rat and Dogfish Shark Choroid Plexus 
Morphology and ultrastructure of shark IV and rat lateral ventricles were studied by 
Villalobos et al (2002). A remarkable similarity was found. In both species a monolayer of 
epithelial cells contains numerous mitochondria and faces the CSF in the ventricles of the 
brain. Tight junctions (zonula occludens) connect the epithelial cells. Blood capillaries are 
fenestrated and blood bathes the basolateral membrane of CP epithelial cells. The apical 
membrane is defined by a dense microvillus border. In Figure 66 electron micrograhs of rat 
lateral (A) and shark IV (B) CPs are shown.  
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Consistent to the similar morphology and ultrastructure of rat and shark CPs, similar transport 
mechanisms for the organic anions FL and FL-MTX were found (Baehr et al., in press; Breen 
et al., 2002; Breen et al., 2004; Miller, 2004; Villalobos et al., 2002). 
Figure 66: Electron micrographs of adult rat lateral CP (A) and shark IV CP (B). In both species CP tissues look 
very similar. The blood vessels are surrounded by a monolayer of epithelial cells. At the apical, CSF facing, 
membrane microvilli are recognizable in rat and shark . MV: microvilli; PV: perivascular space, RBC: red blood 
cells. The images are modified from Villalobos et al., 2002. 
 
 
To analyze differences and similarities of transport processes in rat and shark CPs, one more 
organic anion, the medium sized TR, was used. 
Figure 67: Confocal image of TR (1 µM) transport in shark CP. TR accumulation was highest in 
vascular/perivascular spaces and the interior of blood vessels followed by epithelial cells. Lowest fluorescence 
levels were detected in the bath.  
 
Figure 67 shows a confocal image of dogfish shark CP after incubation with TR 1 µM for 60 
minutes. BBM and BLM can be recognized as refractile elements between cells and medium 
or blood. Beneath CP epithelium is a subepithelial space and blood vessels. Blood vessels 
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contain erythrocytes, which can be seen as areas with low fluorescence intensity in confocal 
images. In Figure 68 transmitted light (A) and confocal images (B) of rat CP are shown. 
Figure 68: Transmitted light (A) and confocal (B) images of TR (2 µM) transport in rat CP. As in shark CP TR 
accumulation was highest in vascular/subepithelial spaces and the interior of blood vessels. Cellular fluorescence 
was lower, bath fluorescence was almost not detectable. 
A B 
  
TR accumulated in epithelial cells and in vascular/subepithelial spaces and the interior of 
blood vessels. Fluorescence intensity was high in vascular/subepithelial spaces and the 
interior of blood vessels (except areas were erythrocytes are located) and lower in epithelial 
cells. Medium fluorescence was lower than cellular fluorescence.  
In Figure 69 the time course of TR accumulation in vascular/subepithelial spaces, the interior 
of blood vessels and epithelial cells in rat CP is shown. TR accumulation (2 µM) reached 
steady state within 60 minutes. Further experiments were carried out with incubation times of 
90 min. Cellular fluorescence was ~42% of fluorescence intensity in vascular/subepithelial 
spaces and the interior of blood vessels at steady state, these findings indicate an effective 
basolateral efflux. Background fluorescence was, different to the findings obtained from 
incubation with fluo-cAMP in rat CP, almost not detectable. This distribution: low 
fluorescence in medium, higher fluorescence in epithelial cells and highest fluorescence in 
vascular/perivascular spaces and the interior of blood vessels, indicates an active two-step 
mechanism for TR transport in rat CP. 
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Figure 69: Time course of TR accumulation in rat CP. TR accumulation reached steady state after 60 minutes. 
Cellular fluorescence was ~42% of fluorescence intensity in vascular/subepithelial spaces and the interior of 
blood vessels. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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 Steady state accumulation in vascular/subepithelial spaces, the interior of blood vessels and 
epithelial cells was saturated using increasing TR concentrations in the incubation solution. 
Rat CPs were incubated with TR at concentrations between 1 and 10 µM. At concentrations 
over 5 µM TR transport started to reach a plateau as well in vascular/subepithelial spaces and 
the interior of blood vessels as in epithelial cells in rat CP (Figure 70). For further 
experiments we used TR at a concentration of 2 µM. 
Figure 70: Concentration dependency of TR transport in rat CP. At concentrations > 5 µM transport started to 
reach a plateau. Data are expressed as mean ± SE of 10 CP blood vessels of one representative isolation.  
0.0 2.5 5.0 7.5 10.0 12.5
0
50
100
150
200
250
lumen
cells
concentration in µM
Fl
u
o
re
sc
en
ce
 
Accumulation of TR was studied in absence and presence of various inhibitors of organic 
anion transport. Figure 71 shows TR 2 µM accumulation in a rat CP (A) and TR distribution 
after incubation with medium containing TR and Na+-taurocholate 25 µM (B). Fluorescence 
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intensity was significantly lower in vascular/subepithelial spaces, the interior of blood vessels 
and epithelial cells after treatment with Na+-taurocholate.  
Figure 71: Overlay of transmitted light and confocal images of rat CP. TR transport is shown in a control CP 
(A) and concominat incubation with TR and Na+-taurocholate. In comparison to control CP, fluorescence in 
vascular/subepithelial spaces, the interior of blood vessels and epithelial cells was reduced after Na+-taurocholate 
treatment. 
A B 
 
 
Figure 72: Effects of Na+-taurocholate on TR transport in rat CP. Na+-taurocholate led to a dose-dependent 
reduction of TR accumulation in vascular/perivascular spaces, the interior of blood vessels and epithelial cells. 
Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly 
different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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In Figure 72 Na+-taurocholate treatment at different concentrations between 1 and 100 µM is 
diagrammed. A dose dependent inhibition of TR transport across rat CP epithelium could be 
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recognized, vascular/subepithelial spaces, the interior of blood vessels and epithelial cells are 
concerned. These results indicate involvement of an Oat or Oatp in TR transport across rat CP 
epithelium. 
TR transport from aCSF to vascular/subepithelial spaces and the interior of blood vessels in 
rat CP is dependent on metabolism. Incubation with NaCN caused a strong decrease in 
vascular/subepithelial and luminal fluorescence. Cellular fluorescence was not affected. Only 
efflux at the basolateral membrane seems to be affected by NaCN (Figure 73 A). NaCN had 
no effect on TR transport in shark CP even at 100 mM (Figure 73 B). This is the first 
difference between TR transport in rat and shark CP. 
Figure 73: Effects of NaCN on TR transport in rat (A) and shark (B) CP. In rat CP NaCN inhibited basolateral 
efflux of TR, in shark no effect was obtained. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001). 
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Increasing medium K+ 10 fold (isoionic Na+ replacement) and subsequent depolarisation of 
epithelial cells had no effect on TR distribution in rat and shark CP (Figure 74 shows the 
effect of increased K+ levels on rat CP, the results obtained from incubation with high K+ ER 
in shark CP are not shown). The depolarisation of epithelial cells did not affect TR 
accumulation in rat or shark CP, TR transport is independent from PD differences. 
Transport proteins mediating TR transport in rat CP seem to be Na+-dependent. Incubation 
with low-Na+ aCSF had no effect on TR accumulation in rat CP, but removing Na+ led to 
much lower fluorescence levels in vascular/subepithelial spaces and the interior of blood 
vessels. Cellular fluorescence was affected as well (Figure 75 A). These results indicate 
 Results 
76   
involvement of Oats on TR transport in rat CP, especially on apical uptake. Na+ replacement 
in shark CP had no effect (Figure 75 B). In shark CP Oatps seem to be concerned with TR 
uptake at the apical membrane of CP epithelium. With these findings we show the second 
important difference between TR transport in rat and shark CP.  
Figure 74: Effects of increasing K+ by an order of magnitude on TR transport in rat CP. High K+ levels and 
therefore depolarisation of epithelial cells did not affect TR transport. Data are expressed as mean ± SE of 10 CP 
blood vessels from one representative isolation.  
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Figure 75: Effects of Na+ replacement on TR transport in rat (A) and shark (B) CP. Incubation with Na+-free 
buffer clearly affected distribution of TR in rat CP, in shark CP Na+ replacement had no effects. Data are 
expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly different from 
control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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To analyze transport proteins mediating basolateral efflux of TR in rat and shark CP we tested 
MK571. The Mrp inhibitor MK571 had a strong inhibitory effect on TR accumulation in 
vascular/subepithelial spaces, the interior of blood vessels and epithelial cells in both, rat 
(Figure 76 A) and shark (Figure 76 B) CP at micromolar concentrations. The effect in shark 
CP was initiated by lower MK571 concentrations than in rat CP. These findings are a sign of 
Mrp involvement in TR transport in rat and shark CP, respectively. 
Figure 76: Effects of MK571 on TR transport in rat (A) and shark (B) CP. MK571 treatment led to reduced 
fluorescence in vascular/perivascular spaces, the interior of blood vessels and epithelial cells in both species. 
Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly 
different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Methotrexate which is a substrate for different Mrps, had an inhibitory effect on TR transport 
in rat CP. Only accumulation in vascular/subepithelial spaces and the interior of blood vessels 
was affected (Figure 77). This result is one more evidence for Mrp participation in TR 
transport in rat CP, especially for one or more Mrps involved in basolateral efflux, because 
only accumulation in vascular/subepithelial spaces and the interior of blood vessels was 
affected. 
LTC4, which is known to inhibit transport processes mediated by Mrp1, Mrp2, Mrp3 and 
Oatps, at a concentration of 0.3 µM had no effect on TR distribution in rat CP tissue (Figure 
78 A). Therefore Mrp1,2,3 and Oatps seem not to be involved in TR transport in rat CP. 
TR transport was examined in Mrp2 deficient TR- rats which are deficient of Mrp2. 
Compared to wistar wildtype rats no differences were obtained for TR transport in rat CP. 
Therefore Mrp2 seems not to play a role in TR transport in rat CP (Figure 78B). 
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Figure 77: Effects of methotrexate on TR transport in rat CP. Incubation with methotrexate led to decreased TR 
accumulation in vascular/subepithelial spaces and the interior of blood vessels, it had no effect on cellular 
accumulation. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. 
(Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Figure 78: Effects of LTC4 (A) and TR- rats (B) on TR transport in rat CP. LTC4 treatment had no effect on TR 
distribution and TR transport was not different in TR- rats compared to wildtype rats. Data are expressed as mean 
± SE of 10 CP blood vessels of one representative isolation. (Significantly different from control values: * for 
P<0.05, ** for P<0.01 and *** for P<0.001). 
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The Mrp4 substrate AZT was added at concentrations up to 50 µM. It did neither affect 
accumulation of TR in vascular/perivascular spaces and the interior of blood vessels nor in 
epithelial cells (Figure 79). It is likely that Mrp4 is not involved in TR efflux at the basolateral 
membrane of rat CP epithelial cells. 
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Figure 79: Effects of AZT on TR transport in rat CP. AZT at concentrations between 1 and 50 µM had no effect 
on TR accumulation. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. 
(Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001).  
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Figure 80: Effects of digoxin (A) and ouabain (B) on TR transport in rat CP. Neither digoxin nor ouabain had 
any effect on TR distribution in vascular/perivascular spaces, the interior of blood vessels and epithelial cells. 
Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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To examine the role of Oatp2 in TR efflux from epithelial cells into blood at the basolateral 
membrane, digoxin, an Oatp2 blocker, was tested. Digoxin had no effect on TR distribution in 
rat CP even at high concentrations (up to 500 µM) (Figure 80 A). The Oatp2 substrate 
ouabain had no effect on TR transport in rat CP as well. Ouabain was used at concentrations 
up to 5 mM (Figure 80 B). 
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Contrary to the findings in rat, digoxin led to reduced fluorescence in vascular/subepithelial 
spaces, the interior of blood vessels and epithelial cells in shark CP. The digoxin effect on TR 
transport in shark CP was dose dependent at concentrations between 5 and 10 µM (Figure 81). 
These results show another interesting difference between TR transport in rat and shark CP. 
In rat CP TR seems to be transported out of the cell by one or more Mrps, in shark CP Oatp2 
and a Mrp seem to be involved in TR efflux at the basolateral membrane. 
Figure 81: Effects of digoxin on TR transport in shark CP. Digoxin had an inhibitory effect on TR transport, 
vascular/perivascular spaces, the interior of blood vessels and epithelial cells were concerned. Data are expressed 
as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly different from control 
values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Estrone sulfate (ES) is a substrate for Mrps, Oats and Oatps. It had a dose dependent 
inhibitory effect on TR transport in rat (Figure 82 A) and in shark (Figure 82 B) CP. 
Fluorescence in vascular/subepithelial spaces and the interior of blood vessels was decreased, 
cellular fluorescence was reduced as well at ES concentrations betweeen 5 and 100 µM. 
These results give additional evidence for Mrps, Oats or Oatps involved in mediation of TR 
transport in rat and shark CP.  
Treatment with probenecid led to reduced fluorescence levels in perivascular/subepithelial 
spaces, the interior of blood vessels and epithelial cells in rat (Figure 83 A) as well as in shark 
CP (Figure 83 B). Involvement of Mrps, Oats or Oatps in transport of TR in rat and shark CP 
is likely. 
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Figure 82: Effects of ES on TR transport in rat (A) and shark (B) CP. ES led to reduced fluorescence in 
vascular/perivascular spaces, the interior of blood vessels and epithelial cells. In rat CP cellular fluorescence was 
only affected by ES at a concentration of 50 µM. Data are expressed as mean ± SE of 10 CP blood vessels from 
one representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001).  
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Figure 83: Effects of probenecid on TR transport in rat (A) and shark (B) CP. Probenecid reduced TR 
accumulation in vascular/subepithelial spaces, the interior of blood vessels and in epithelial cells. Data are 
expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly different from 
control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Bromosulfophthalein (BSP) is a substance that affects transport processes mediated by Mrps, 
Oats and Oatps. In the present study we used BSP in micromolar concentrations that led to 
decreased TR accumulation in vascular/subepithelial spaces, the interior of blood vessels and 
epithelial cells in rat CP (Figure 84). Therefore we can assume that Mrps, Oats or Oatps are 
involved in TR transport in rat CP. Due to the results shown previously, we can exclude 
Mrp1, Mrp2, Mrp4 and Oatps from being involved in TR transport in rat CP tissue. 
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Figure 84: Effects of BSP on TR transport in rat CP. BSP had an inhibitory effect on TR transport. Data are 
expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly different from 
control values: * for P<0.05, ** for P<0.01 and *** for P<0.001).  
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Figure 85: Effects of PAH and cimetidine on TR transport in rat (A) and shark (B) CP. Cimetidine had a weak 
effect on TR transport in rat CP at 5mM, cellular fluorescence was decreased as well as fluorescence in 
vascular/perivascular spaces and the interior of blood vessels. PAH had no effect on TR transport in rat CP. In 
shark CP cimetidine did not affect TR transport, but PAH had a weak effect on luminal fluorescence at 1 mM. 
Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. (Significantly 
different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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To characterize TR uptake from aCSF/ER into epithelial cells at the apical membrane, we 
investigated the effects of cimetidine and PAH, both substrates of Oat1 and Oat3. TR 
transport in rat CP was only affected by cimetidine at a high concentration (5mM), this effect 
was only weak (Figure 85 A). Cimetidine had no effect on TR transport in shark CP (Figure 
85 B) at millimolar concentrations. In rat CP PAH treatment had no effect on TR 
accumulation (Figure 85 A). In shark CP a weak effect on TR distribution could be 
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recognized (Figure 85 B), only luminal accumulation of TR was affected. These results 
favour an involvement of one or more Na+-dependent transport proteins, most likely Oats, but 
not Oat1 or Oat3, in TR transport in rat CP. In shark CP no Na+-dependent constituent is 
involved in TR transport. 
2,4-D had a decreasing effect on FL accumulation in vascular/perivascular spaces, the interior 
of blood vessels and epithelial cells in rat and shark CP (Breen et al., 2002), but had no effect 
on TR distribution in rat (Figure 86 A) or shark (Figure 86 B) CP. Transport proteins involved 
in transport of the medium sized organic anion TR seem to be different from those 
transporting the smaller sized FL in rat and shark CP, respectively. 
Figure 86: Effects of 2,4-D on TR transport in rat (A) and shark (B) CP. 2,4-D did not affect TR transport in rat 
and shark CP respectively. Data are expressed as mean ± SE of 10 CP blood vessels from one representative 
isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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To investigate into regulatory processes mediating transport of TR in shark CP, we analyzed 
the effects of PKC and PKA activation. As described above activation of proteinkinase C 
(PKC) downregulates Oat3 action. In contrast activation of proteinkinase A (PKA) leads to 
upregulation of Oat3 mediated transport.  
PKC can be activated by phorbol ester, but incubation with PMA at concentrations from 1 nM 
to 100 nM did not affect TR accumulation in vascular/subepithelial spaces, the interior of 
blood vessels and epithelial cells in shark CP (Figure 87). PKC seems not to be involved in 
regulation of TR transport in shark CP. 
To examine if PKA activation increased TR excretion in shark CP we used the indirect PKA 
activator forskolin. At the used concentration 10 µM forskolin had an inhibitory effect on TR 
distribution in the tissue, fluorescence was decreased in vascular/subepithelial spaces and the 
 Results 
84   
interior of blood vessels, epithelial cell fluorescence was not concerned (Figure 88). The same 
was found for TR transport in shark rectal salt gland tubules, but there was no evidence for 
mediation of this effect by PKA (Miller et al., 2002). Different from this result, an activation 
of FL-MTX transport in shark CP was found using forskolin at a concentration of 10 µM. Due 
to the abolishment of the forskolin effect by the PKA inhibitor H-89, PKA involvement was 
ascertained (Baehr et al., in press).  
Figure 87: Effects of PMA on TR transport in shark CP. PMA, at concentrations between 1 and 100 nM, had no 
effect on TR distribution in vascular/subepithelial spaces, the interior of blood vessels and epithelial cells. Data 
are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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Figure 88: Effects of forskolin on TR transport in shark CP. Forskolin treatment led to reduced TR 
accumulation in vascular/perivascular spaces and the interior of blood vessels, TR accumulation in epithelial 
cells was not affected. Data are expressed as mean ± SE of 10 CP blood vessels from one representative 
isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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To test whether the forskolin effect is caused by PKA activation we used the direct PKA 
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activator cAMP. cAMP did not affect TR transport in shark CP at concentrations of 1 and 10 
µM (Figure 89). Thus the forskolin effect seems to be provoked by forskolin itself and not by 
high intracellular cAMP levels caused by forskolin. PKA seems not to be involved in the 
forskolin effect. Taken together these results, PKC and PKA activation are not involved in 
regulation of TR transport in shark CP. 
Figure 89: Effects of cAMP on TR transport in shark CP. cAMP did not affect distribution of TR within CP 
tissue. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation.  
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4.2.3.4 Regulation of Fluorescein-Methotrexate Transport in Rat Choroid Plexus 
Regulation of FL-MTX transport was investigated by Baehr et al. (in press) in dogfish shark 
CP. Here we demonstrate the results found for regulatory processes concerning FL-MTX 
transport in rat CP.  
From previous studies we know that transport proteins involved in FL-MTX transport in rat 
and dogfish shark CP epithelium are the same, but regulation of FL-MTX transport in rat and 
shark CP was not compared by now. 
In Figure 90 major characteristics of FL-MTX transport in rat CP are shown. FL-MTX 
accumulates in vascular/perivascular spaces and the interior of blood vessels, cellular 
fluorescence intensities are low, as bath fluorescence is. At the apical membrane an area of 
higher fluorescence is located. This indicates a strong apical efflux. 
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Figure 90: Major characteristics of FL-MTX transport in rat CP. FL-MTX accumulation is highest in 
vascular/subepithelial spaces and the interior of blood vessels. Cellular fluorescence barely exceeded bath 
fluorescence. At the apical membrane an area of high fluorescence is recognizable. 
 
In Figure 91 A a control CP and in Figure 91 B a CP after concominant incubation with 
forskolin and FL-MTX are shown. Forskolin affected FL-MTX accumulation in 
vascular/perivascular spaces and the interior of blood vessels, epithelial cells were not 
concerned. Fluorescence intensities in vascular/perivascular spaces and the interior of blood 
vessels were higher than in control CPs using different concentrations (5-50 µM) of forskolin 
(Figure 92). These results indicate activation of efflux transporters for FL-MTX caused by 
PKA activation.  
Figure 91: Forskolin effect on FL-MTX transport in rat CP. Forskolin, at a concentration of 10 µM (B), led to 
increased fluorescence in vascular/subepithelial spaces and the interior of blood vessels compared to control (A). 
Cellular fluorescence was not affected.  
A B 
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To examine whether this activation is actually caused by PKA activation, we incubated with 
forskolin and H-89 as described above. The PKA inhibitor H-89 had no effect on FL-MTX 
transport in rat CP on its own, but could alter the forskolin effect (Figure 93). PKA seems to 
be involved in regulation of FL-MTX transport in rat CP. 
Figure 92: Effects of forskolin on FL-MTX transport in rat CP. Forskolin led to increased FL-MTX 
accumulation in vascular/subepithelial spaces and the interior of blood vessels. Cellular accumulation was not 
affected. Data are expressed as mean ± SE of 10 CP blood vessels of one representative isolation. (Significantly 
different from control values: * for P<0.05, ** for P<0.01 and *** for P<0.001). 
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Figure 93: Effects of forskolin and H-89 on FL-MTX transport in rat CP. As described above forskolin led to 
higher fluorescence levels in vascular/perivascular spaces and the interior of blood vessels. H-89 had no effect 
but could alter the forskolin effect. Data are expressed as mean ± SE of 10 CP blood vessels from one 
representative isolation. (Significantly different from control values: * for P<0.05, ** for P<0.01 and *** for 
P<0.001). 
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To analyze the effect of PKC on FL-MTX transport in rat CP, PMA was used at 
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concentrations up to 1 µM. PMA had no effect on FL-MTX transport suggesting no 
involvement of PKC. Incubation with the PKC inhibitor bisindolylmaleimide (BIM) did not 
affect FL-MTX transport in rat CP as well (Figure 94). Taken together, these results exclude 
PKC involvement in regulation of FL-MTX transport in rat CP. 
Figure 94: Effects of PMA and BIM on FL-MTX transport in rat CP. Both substances had no effect on FL-MTX 
transport. Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. 
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Figure 95: Effects of EGF on FL-MTX transport in rat CP. At concentrations up to 100 ng/ml EGF did not 
affect FL-MTX accumulation in vascular/subepithelial spaces, the interior of blood vessels and epithelial cells. 
Data are expressed as mean ± SE of 10 CP blood vessels from one representative isolation. 
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To examine contribution of the MAPK pathway, EGF was used at concentrations between 1 
and 100 ng/ml. EGF leads to phosphorylation of mitogen-activated/extracellular signal-
regulated kinase (MEK), extracellular signal-regulated kinase 1 and 2 (ERK1/2) and 
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phospholipase A2 (PLA2), this cascade ends in PKA activation via adenylate cyclase 
activation (Soodvilai et al., 2004). 
EGF had no effect on FL-MTX accumulation in rat CP epithelium, luminal and cellular 
fluorescence did not differ compared to fluorescence in control CPs (Figure 95). 
The MEK inhibitor U0126 did not affect FL-MTX transport at concentrations of 1 to 50 µM 
(Figure 96). Taken together with the results obtained from experiments using EGF, the 
MAPK pathway seems not to play a role in regulation of FL-MTX transport in rat CP. 
Figure 96: Effects of U0126 on FL-MTX transport in rat CP. U0126 had no effects on FL-MTX accumulation in 
vascular/perivascular spaces, the interior of blood vessels and epithelial cells. Data are expressed as mean ± SE 
of 10 CP blood vessels from one representative isolation. 
0.0 1.0 10.0 50.0
0
100
200
300 lumen
cells
U0126 in µM
Fl
u
o
re
sc
en
ce
 
 
 Discussion 
90   
5 Discussion 
In the presented project we analyzed transport mechanisms for organic anions in different 
models including killifish proximal tubules, rat and dogfish shark choroid plexus (CP) and 
MDCKII-MRP2 and Sf9-MRP4 cell membrane vesicles. We analyzed molecular and 
functional aspects of transport of the fluorescent dyes fluo-cAMP, texas red (TR) and 
fluorescein-methotrexate (FL-MTX) using RT-PCR, indirect immunohistochemistry and 
confocal laserscanning microscopy. Functional analyses were carried out using different 
inhibitors and activators of organic anion transport. To give an overview of transport proteins 
for organic anions expressed in kidney and CP. Figure 97 shows schematic diagramms of CP 
and proximal tubules epithelial cells and transport proteins expressed in both tissues. 
Figure 97: Schematic diagramms of CP (A) and proximal tubules (B) epithelial cells. Transport proteins are 
expressed to both membranes of the polarized epitheliums. In CP (A) the apical membrane is the cerebrospinal 
fluid site, the basolateral membrane faces the blood. In kidney proximal tubules (B) the apical membrane faces 
the urine, the basolateral membrane faces the blood. Only transporters are shown that are clearly localized to one 
membrane by immunostaining. Bcrp: breast cancer resistance protein; Mrp: multidrug resistance-associated 
protein; Oat: organic anion transporter; Oatp: organic anion transporting polypeptide; Pgp: P-glycoprotein. 
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As described above we performed functional analyses with fluorescent dyes with inhibitors or 
activators of organic anion transport added. Summarizing the results from different 
inhibitor/activator studies we could draw conclusions about transport proteins involved in 
transport of the particular fluorescent dye. In Table 6 the used inhibitors or activators of 
organic anion transport and their inhibitory mechanisms are shown. Most of the shown 
substances affect transport processes mediated by several transport proteins, some substances 
have higher affinities to one transporter family or to one transport proteins.  
 Discussion 
 91 
Table 6: Inhibitors and activators of organic anion transport and mechanisms driving their effects. Only 
substances are shown, that were used in the presented study. 
Modulators Mechanisms 
Adefovir (PMEA) Mrp4 
Azidothymidine (AZT) Mrp4 
Bisindolylmaleimide (BIM) Proteinkinase C (PKC) inhibitor 
8-Bromo-cGMP Mrp4,  
Bromosulfophthalein (BSP) Mrps, Oats, Oatps 
cAMP Mrp4, PKA activator 
Cimetidine Oat1, Oat3 
cGMP Mrp4 
Dibutyryl cAMP (db-cAMP) Proteinkinase A (PKA) activator 
2,4-dichlorophenoxyacetic acid (2,4-D) Inhbits fluorescein transport 
Digoxin Oatp2 
Dipyridamole Mrps 
Epidermal growth factor (EGF) Activation mitogen activated proteinkinase pathway 
(MAPK) 
Estrone Sulfate (ES) Mrps, Oats, Oatps 
Endothelin 1 (ET1) PKC activator 
Forskolin PKA activator 
H-89 PKA inhibitor 
High Potassium (high K+) Inhibits potential differences sensitive transport 
processes  
Leukotriene C4 (LTC4) Mrp1, 2, 3; Oatps 
Methotrexate Mrps 
MK571 Mrps 
NaCN Metabolic poison: inhibits active transport processes 
Nitroprusside-Na+ NO-donor, activation PKC 
Ouabain Oatp2, Na+-dependent transport processes 
p-Aminohippurate (PAH) Oat1, Oat3, Mrp2, Mrp4 
Phorbol-12-myristate-13-acetate (PMA) PKC activation 
Probenecid Mrps, Oats, Oatps 
Prostaglandin E2 (PGE2) Mrp4 
Sodium free (Na+-free) Oats 
Taurocholate-Na+ Oats, Oat 
U0126 MEK1/2, inhibition MAPK 
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Involvement of specific transport proteins in transport of one substance can only be evidenced 
by combining results from multiple inhibitor studies.  
 
5.1 Fluo-cAMP Transport in Killifish Proximal Tubules 
One aim of our research project was the investigation of organic anion transport in choroid 
plexus (CP) tissue. Since CP function is similar to function of the kidney and similar transport 
proteins are expressed in CP and kidney epithelium (Kusuhara et al., 2004; Miller, 2004; 
Breen et al., 2004), we used renal proximal tubules as a comparative model. As the kidney is 
responsible for homeostasis in blood, the CP is an important organ for homeostasis in the CSF 
(Spector/Johanson, 1991). Renal tubules of the teleost killifish represent a renal clearance 
system similar to the one of mammals with transport proteins being at the same 
morphological position (Pritchard and Miller, 1991). Mrp2 is located to the apical membrane 
of killifish proximal tubules (Masereeuw et al., 2000) and here we demonstrate the same 
localization for Mrp4.  
We used this physiological similarities to study the excretory mechanisms of the fluorescent 
cAMP analog fluo-cAMP, which seems to be transported by the same transporters as 
nucleoside and nucleotide analogs being used in clinical practice for HIV treatment. 
Participation of these transporters is of particular interest for the assessment of the disposition 
of these drugs since they determine the rate and extent of access to HIV sanctuaries like the 
central nervous system (Bachmayer et al., 2005; Miller et al., 2000; Park and Sinko, 2005) as 
well as the extent of excretion by renal cells (Schaub et al., 1997, Van Aubel et al., 2002).  
Tubular secretion of fluo-cAMP is a concentrative two-step mechanism composed of 
basolateral uptake from blood into epithelial cells at the basolateral membrane and apical 
efflux into urine. We found evidences that both transport proteins Mrp2 and Mrp4 are 
involved in fluo-cAMP cell to lumen transport at the apical membrane in killifish proximal 
tubules. The teleost analogs of Mrp4 and Mrp2 are located to the apical membrane of 
proximal tubules epithelial cells in killifish kidney. 
The inhibitory effect of LTC4 on fluo-cAMP transport as well as the inhibition by ES, 
probenecid, PAH and MK571 is similar to the inhibition pattern previously seen for FL-MTX 
transport (Masereeuw et al., 1996; Breen et al., 2004; Miller et al., 2002a) and suggest 
participation of Mrp2. The strong inhibitory effect of LTC4, especially on cellular 
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fluorescence, leads also to the assumption that an Oatp is involved in fluo-cAMP uptake into 
proximal tubulus epithelial cells. 
On the other hand, the Mrp4 substrates PMEA and AZT had inhibitory effects on fluo-cAMP 
accumulation in tubular lumen, whereas the same concentrations did not affect transport of 
the Mrp2 substrate FL-MTX, suggesting differences in the affinity of fluo-cAMP and FL-
MTX. cAMP itself reduced fluo-cAMP accumulation in an assumably competitive manner. 
The phosphodiesterase inhibitor 8-Br-cGMP, which increases cellular cAMP levels, reduced 
fluorescence levels in proximal tubular lumens as well. Taken together, these results indicate 
involvement of Mrp4 in fluo-cAMP transport in killifish proximal tubules.  
 
5.2 Fluo-cAMP Transport in Membrane Vesicles 
To confirm the role of MRP2 and MRP4 in fluo-cAMP transport, we tested transport 
processes in Sf9-MRP4 and MDCKII-MRP2 membrane vesicles. We found that MRP2 and 
MRP4 mediate fluo-cAMP transport with the same affinity (Km values were 4.8 and 5.3 µM, 
respectively). Compared with the Km value for FL-MTX transport in MDCKII-MRP2, which 
is around 10 µM (J.J.M.W. van den Heuvel, personal communication), fluo-cAMP seems to 
have a higher affinity for MRP2 than FL-MTX. Interestingly fluo-cAMP is a high affinity 
substrate for MRP4 as well. Contrary to these findings the high affinity Mrp2 substrate FL-
MTX is transported selectively by MRP2. FL-MTX is not transported by MRP4 in Sf9-MRP4 
vesicles (R. Masereeuw, personal communication). As fluo-cAMP, the organic anion PAH is 
a substrate for both, MRP2 expressed in MDCKII cells and MRP4 expressed in Sf9 cells. In 
opposition to transporter affinities for fluo-cAMP, MRP2 (Km value 2.1 ± 0.6 mM) and 
MRP4 (Km 160 ± 50 µM) show only low affinities to PAH (Smeets et al., 2004). 
Summarizing these results, fluo-cAMP seems to have a high affinity to MRP2 and MRP4, 
even higher than the affinity of FL-MTX to MRP2 and much higher than affinities of the low 
affinity substrate PAH to both transporters. These results are very interesting, because 
normally high affinity substrates show high affinity to one of the transporters, as described for 
FL-MTX. With fluo-cAMP we found a high affinity substrate for both, MRP2 and MRP4. 
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5.3 Regulation of Fluo-cAMP Transport in Killifish Kidney 
For further comparison of transport processes mediated by Mrp2 and Mrp4 in killifish 
proximal tubules, we investigated into regulatory mechanisms for fluo-cAMP transport. The 
ET pathway signaling through PKC starts with the binding of ET1 to the ETB receptor and a 
subsequent cascade via NO-synthase and PKC. ET signaling involves activation of an ET 
receptor-coupled G protein which in turn activates phospholipase C and PKC (Notenboom et 
al., 2002). In contrast to FL-MTX transport mediated by Mrp2, transport of fluo-cAMP in 
killifish proximal tubules seems to be independent from ET pathway. Neither ET1 nor the 
PKC activator PMA or NO donor nitroprusside-Na+ had an effect on fluo-cAMP transport in 
killifish kidney proximal tubules. Summarizing these results, ET pathway and activation of 
PKC are not involved in regulation of fluo-cAMP transport in killifish proximal tubules. 
We know that transport of ES mediated by Oat1 and Oat3 in rabbit proximal tubules is up-
regulated by activation of PKA (Sauvant et al., 2004; Soodvilai et al., 2004). Contrary to these 
findings, db-cAMP, a direct activator of PKA, had no effect on fluo-cAMP accumulation. To 
clarify this effect we used the indirect PKA activator forskolin which inhibits 
phosphodiesterase and causes increasing intracellular cAMP levels. Forskolin had an 
inhibitory effect on fluo-cAMP transport, presumably caused by increased cAMP levels, 
because the direct PKA activator db-cAMP did not effect fluo-cAMP transport. H-89, a PKA 
inhibitor, could not alter the forskolin effect, suggesting inhibition by forskolin is independent 
from PKA activation. 
Taking together these results, regulation of fluo-cAMP transport in killifish proximal tubules 
is apparently not mediated via PKC and PKA. This is different to results found for FL-MTX 
transport mediated by Mrp2 in killifish proximal tubules, which is sensitive to nanomolar 
concentrations of ET1 or PMA (Masereeuw et al., 2000). Thus, the regulatory mechanisms 
underlying the excretion of fluo-cAMP in killifish proximal tubules remain to be identified. 
 
5.4 Fluo-cAMP Transport in Rat Choroid Plexus 
Since the brain is an important sanctuary for HIV (Miller et al., 2000; Bachmayer et al., 2005; 
Park and Sinko, 2005) it is crucial to know more about barrier functions in the brain and 
transport proteins involved in active transport processes overcoming those barriers. CP 
epithelium which forms the blood-cerebrospinal fluid (CSF)-barrier is significantly involved 
in excretion of xenobiotic compounds and metabolites from CSF into blood (Nishino et al., 
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1999). To analyze transport processes across the blood-CSF barrier, we researched into 
transport of different substrates across CP epithelium. Transport processes were regarded in 
direction from aCSF into blood, comparable to excretion processes in CP epithelium. 
In rat CP the findings for fluo-cAMP transport are different to those obtained for transport in 
killifish proximal tubules. Transport proteins mediating transport of the fluorescent cAMP 
analog fluo-cAMP are others in rat CP than in killifish proximal tubules. Fluo-cAMP 
accumulation in rat CP is an active two-step mechanism that is metabolism driven, NaCN 
treatment caused a decrease in luminal accumulation. Fluo-cAMP distribution was highest in 
vascular/perivascular spaces and the interior of blood vessels followed by epithelial cells and 
bath. Fluorescence in epithelial cells was only quite higher compared with bath fluorescence. 
Fluo-cAMP transport is composed of two steps, Na+-dependent uptake at the apical 
membrane and potential differences (PD) insensitive efflux at the basolateral membrane of CP 
epithelium. The inhibitory effects of ES and probenecid indicate involvement of Mrps, Oatps 
or Oats in fluo-cAMP transport in rat CP. 
By immunocytological staining we showed, that Mrp4 is located to the basolateral membrane 
of CP epithelium, as well as Mrp1 and Oatp2 (Kusuhara et al., 2004; Miller, 2004, Breen et 
al., 2004), in rat. This localization was evidenced by functional analyses using the Mrp4 
substrate [3H]-cGMP as well. On basis of the results obtained from functional analyses in 
killifish proximal tubules, we assumed involvement of Mrp4 in transport of fluo-cAMP in rat 
CP. To prove this speculation, we tested various substrates for Mrp4, including adefovir, 
AZT, cAMP, cGMP and PGE2. Non of these compounds had any effect on fluo-cAMP 
transport across rat CP epithelium, suggesting that Mrp4 is not involved in fluo-cAMP 
transport, especially basolateral efflux. But the results obtained from different inhibition 
studies led to the presumption that one or more transport proteins belonging to the Mrp family 
are involved in mediation of fluo-cAMP transport in rat CP: the Mrp inhibitor MK571 
reduced fluo-cAMP accumulation, the effect was strong. LTC4 had an inhibitory effect as 
well, but only fluorescence in vascular/perivascular spaces and the interior of blood vessels 
was reduced, suggesting an inhibition of basolateral efflux. The LTC4 effect only on luminal 
accumulation of fluo-cAMP in rat CP, in addition to the effect of MK571, leads to the 
assumption that Mrp1 is involved in basolateral efflux from epithelial cells into blood in rat 
CP. From experiments with Mrp2 deficient TR- rats we know, that Mrp2 plays no role in fluo-
cAMP transport in rat CP. Another transport protein localized to the basolateral membrane of 
rat CP is Oatp2 (Kusuhara et al., 2004; Miller, 2004, Breen et al., 2004), but this protein is not 
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involved in fluo-cAMP transport in rat CP, as the Oatp2 inhibitor digoxin had no effect, even 
at high concentrations. 
Apical efflux into CP epithelial cells is Na+-dependent, as shown by removing Na+ from 
incubation medium, indicating an Oat involved in uptake from aCSF into CP epithelial cells. 
The inhibitory effects of Na+-taurocholate treatment are evidence for participation of an Oat 
or Oatp as well, but Oatps mediate transport of their substrates in a Na+-independent manner. 
rOat3 is the most abundant Oat isoform expressed in CP epithelium and located to the apical 
membrane (Miller, 2004), but is not involved in fluo-cAMP uptake at the apical membrane of 
CP epithelial cells. rOat1 is only expressed at low levels in rat CP, it was detected only at 
RNA level (Choudhuri et al., 2003), but protein expression could not be verified (Kusuhara et 
al., 2004). From the PAH effect it can be concluded that neither Oat1 or Oat3 nor Mrp2 or 
Mrp4 are involved in mediating transport of fluo-cAMP in rat CP. As found for ES and 
taurocholate transport in mice CP (Sykes et al., 2004) and FL-MTX transport in rat CP (Breen 
et al., 2004), one or more Na+-dependent transporters different from Oat3 are involved in 
fluo-cAMP uptake at the apical membrane of rat CP epithelium. mRNA expression of one 
more member of the Oat family, Oat2, was described by Choudhuri et al., 2003. But 
localization of this protein is not evidenced by now. 
Taking together these results, fluo-cAMP transport in rat CP is an active two-step mechanism 
composed of apical uptake mediated by one or more Na+-dependent transport proteins and 
basolateral efflux mediated by a Mrp, most probably Mrp1.  
 
5.5 Comparison of Fluo-cAMP and Fluorescein Transport 
As described above, fluo-cAMP is a cAMP analog with FL coupled to C8 via a six-atom 
spacer. We compared fluo-cAMP transport with transport of its substituent, the small-sized 
Fluorescein (FL).  
FL transport across CP epithelium is a concentrative two-step mechanism consisting of Na+-
dependent uptake from aCSF into epithelial cells at the apical membrane and PD-driven 
efflux into blood at the basolateral membrane (Breen et al., 2002). The first differences 
between transport of FL and fluo-cAMP can be recognized from those findings, basolateral 
efflux of fluo-cAMP was PD-insensitive. A second difference is, that transport of FL is 
affected by treatment with the herbicide 2,4-D (Breen et al., 2002) which had no effects on 
fluo-cAMP transport. As proved by Sykes et al (2004) in mice CP, apical uptake of FL is 
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mediated by Oat3. Different to the effect on fluo-cAMP transport, LTC4 had no effect on 
transport of FL in rat CP. Mrp1, Mrp2, Mrp3 and Oatps seem not to be involved in basolateral 
efflux of FL in rat CP. Transport proteins involved in PD-driven FL efflux at the basolateral 
membrane of CP epithelium are not evidenced by now (Breen et al., 2002). Combining these 
results, fluo-cAMP transport is mediated by different proteins than transport of its substituent 
FL in rat CP. This is an evidence for fluo-cAMP being stable and transported as a whole in rat 
CP. 
 
5.6 Comparison of Fluo-cAMP and FL-MTX Transport 
Due to the similarity of molecular weights for both substances (fluo-cAMP: 815.7, Da FL-
MTX: 979.1 Da) a further interesting comparison is the one between transport of fluo-cAMP 
and fluorescein-methotrexate (FL-MTX) in rat CP. Transport of FL-MTX in rat CP is a 
concentrative, metabolism-driven two-step mechanism as well as transport of fluo-cAMP. 
Apical uptake of FL-MTX is Na+-dependent, basolateral efflux is insensitive to PD. FL-MTX 
accumulation is in vascular/subepithelial spaces and the interior of blood vessels > medium > 
epithelial cells (Breen et al., 2004). This distribution is different to distribution of fluo-cAMP 
in rat CP which was in vascular/perivascular spaces > epithelial cells > medium. Na+-
dependent uptake and PD-insensitive efflux were in the same manner for both substances. 
Mrp1 is involved in basolateral efflux of FL-MTX (Breen et al., 2004) in rat CP epithelium as 
well as in fluo-cAMP efflux at the basolateral membrane, but different to FL-MTX efflux, 
Oatp2 plays no role in mediation of fluo-cAMP efflux at the basolateral membrane. Oat3 is 
not involved in apical uptake of both substances in rat CP. For FL-MTX transport 
experiments with an Oat3-null mouse brought evidence for Oat3 not being a party of FL-
MTX transport. The Na+-dependent transporter mediating transport of FL-MTX in rat CP 
remains to be found (Breen et al., 2004). Summarizing these results, we found similarities 
between fluo-cAMP and FL-MTX transport in rat CP. Both substances are transported by 
Mrp1, but FL-MTX efflux is also mediated by Oatp2. For both fluorescent dyes apical uptake 
is Na+-dependent and the transporter (s) involved remain (s) to be identified.  
 
5.7 Regulation of Fluo-cAMP and FL-MTX Transport 
To characterize further differences or similarities concerning transport mechanisms driving 
transport of fluo-cAMP and FL-MTX in rat CP, we investigated into regulatory processes 
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behind those mechanisms. We found differences in regulatory pathways for transport of fluo-
cAMP and FL-MTX in rat CP. The indirect PKA activator forskolin had an inhibitory effect 
on fluo-cAMP transport, that could not be altered by the PKA inhibitor H-89. That result 
leads to the presumption, that PKA is not involved in regulation of fluo-cAMP transport in rat 
CP. Different to those findings, forskolin led to increased FL-MTX accumulation in 
vascular/perivascular spaces and the interior of blood vessels in rat CP, this effect could be 
altered by H-89. Therefore, PKA activation seems to cause an activation of FL-MTX efflux at 
the basolateral membrane of CP epithelium in rat. This is one more important difference 
between transport mechanisms for fluo-cAMP and FL-MTX in rat CP. The endothelin 
pathway, including ET1 binding on ETB receptor and a subsequent cascade via NO-synthase 
and activation of PKC, is not a part of regulation for neither fluo-cAMP nor FL-MTX 
transport in rat CP. Concerning the MAPK pathway (described in results), we found 
differences between both substances. The MEK1/2 inhibitor U0126 had a strong inhibitory 
effect on fluo-cAMP transport, but FL-MTX transport was not affected by U0126 at the same 
concentrations. EGF had no effects on both, transport of fluo-cAMP and FL-MTX. We 
assume that the MAPK pathway is not involved in regulation of fluo-cAMP transport in rat 
CP, because EGF could not alter the U0126 effect. The U0126 effect seems to be independent 
from MAPK pathway activation. With regard to regulatory mechanisms driving transport of 
fluo-cAMP and FL-MTX in rat CP, respectively, we found more differences. PKA is involved 
in regulation of FL-MTX transport but not of fluo-cAMP transport, but fluo-cAMP transport 
is affected by the MEK1/2 inhibitor, this effect seems to be independent from the MAPK 
pathway. Although FL-MTX and fluo-cAMP have a similar molecular weight, transport 
mechanisms for both are different in total, even though we found some similarities. 
 
5.8 FL and FL-MTX Transport in Shark Choroid Plexus 
For the small-sized molecule FL and the larger FL-MTX, respectively, similarities in 
transport mechanisms across CP epithelium in different species, rat and dogfish shark, were 
found. We investigated regulation of FL-MTX in rat CP and compared it with regulatory 
processes driving transport of FL-MTX in dogfish shark CP. FL-MTX transport is composed 
of Na+-dependent uptake at the apical membrane and basolateral efflux mediated by Mrp1 and 
Oatp2 in both, rat and dogfish shark CP (Breen et al., 2004; Baehr et al., in press). PKA is 
involved in regulation of FL-MTX in dogfish shark CP, we found the same for FL-MTX 
transport in rat CP. But different to the findings in rat CP, activation of PKC using PMA, led 
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to reduced FL-MTX accumulation in vascular/perivascular spaces, the interior of blood 
vessels and epithelial cells in shark CP. The PMA effect could be altered by the PKC inhibitor 
BIM (Baehr et al., in press). In dogfish shark CP, but not in rat CP, PKC activation leads to 
downregulation of FL-MTX transport. Here we showed differences concerning regulatory 
processes in rat and dogfish shark CP for the first time. 
 
5.9 Texas Red Transport in Rat and Shark CP 
As described above, similar transport mechanisms for FL and FL-MTX were found in rat and 
dogfish shark CP. In the present study we examined transport of the medium-sized organic 
anion texas red (TR) in rat and dogfish shark CP and compared it with transport of FL and 
FL-MTX. Different to FL and FL-MTX transport, TR transport is different in both species. 
This is important due to the use of dogfish shark CP as a model for transport processes in 
mammalian CP.  
Dogfish shark CP was used by reason of its larger size, better accessibility, less fragility and 
longer viability in ex vivo experiments compared with rat CP. The ultrastructure of rat and 
shark CP are similar to each other as described in results (Villalobos et al., 2002), but only 
little molecular and immunohistochemical information on shark CP is available. Interpretation 
of results obtained in shark CP depends on data from mammalians. 
In the study we found specific and concentrative transport mechanisms for TR in both 
species, rat and dogfish shark. But transport proteins involved in TR transport in CP seem to 
be different for both species. By confocal microscopy we could visualize TR transport from 
aCSF (ER) into blood across CP epithelium, TR accumulation was in vascular/perivascular 
spaces and the interior of blood vessels > epithelial cells > medium. By the use of different 
modulators of organic anion transport, we could draw conclusions about transport proteins 
involved in TR transport. 
 
In rat CP the results indicate an active two-step mechanism for transepithelial TR transport, 
transport processes seem to be Na+-dependent, not PD-driven, but dependent on metabolism. 
TR transport in rat CP was affected by ES, BSP and probenecid, these results give evidence 
for transport mechanisms mediated by Oats, Oatps or Mrps. Na+-dependent uptake is typical 
for transport processes mediated by Oats. In rat CP the most abundant Oat isoform is Oat3, 
Oat1 is only expressed at low levels (Kusuhara et al., 2004). Transport processes mediated by 
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Oat1 or Oat3 should have been inhibited by PAH or cimetidine treatment. But PAH had no 
effect and cimetidine only a weak effect on TR transport in rat CP. Therefore, one or more 
Na+-dependent transport proteins different from Oat1 and Oat3 seem to be involved in TR 
transport, but these proteins remain to be analyzed. The inhibitory effect of the Mrp inhibitor 
MK571 indicates a Mrp involved in TR transport in rat CP, but LTC4, that is an inhibitor of 
i.a. Mrp1 mediated transport, had no effect on TR transport: Mrp1 seems not to be involved in 
the transport process of TR in rat CP. Methotrexate had an inhibitory effect on basolateral 
efflux into blood in rat CP epithelium, that result give us one more evidence for a Mrp 
involved in TR transport in rat CP. mRNA of Mrps different from Mrp1 was detected in CP 
(Choudhuri et al., 2003), but localization is not analyzed by now. We also tested the Oatp2 
selective inhibitor digoxin, but it had no effect on TR transport in rat CP, Oatp2 seems not to 
be involved in basolateral TR efflux into blood in rat CP. 
 
Interestingly, transport processes in shark CP seem to be Na+-independent and not metabolism 
driven. Like TR transport in rat CP, transport in shark CP is not PD-driven. Na+-independent 
uptake at the apical membrane indicates involvement of an Oatp. Because Oatp3 is the most 
abundant isoform in CP and located to the apical membrane (Kusuhara et al., 2004), it is 
likely that Oatp3 is involved in apical TR uptake in dogfish shark CP. Furthermore TR 
transport in shark CP was affected by ES and probenecid, these results can be more evidences 
for an Oatp involved in TR transport. The Oat1 and 3 inhibitors cimetidine and PAH had no 
or only a weak effect on TR accumulation at millimolar concentrations. These results are 
against an involvement of Oat1 and Oat3 in transport of TR in dogfish shark CP. Regarding 
the basolateral efflux step, different results were found for TR transport in rat and shark CP as 
well. MK571 had an inhibitory effect on TR transport in shark as well as in rat CP. This leads 
to the suggestion that a Mrp is involved in transport, most likely Mrp1. The second 
transporter involved in TR efflux at the basolateral membrane in shark CP seems to be Oatp2, 
because treatment with digoxin led to decreased fluorescence levels. 
 
Summarizing the results, TR transport in rat CP is an active two-step mechanism which is 
metabolism driven, Na+-dependent and PD-insensitive. The transport protein(s) involved in 
apical uptake are Na+-dependent, but remain(s) to be identified. It is likely, that a Mrp 
different from Mrp1, Mrp2 and Mrp4 is involved in basolateral efflux, but we don’t know by 
now, which one (or more) is concerned. 
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In shark CP TR transport is an active two-step mechanism as well. It is not metabolism 
driven, but Na+-independent and not PD-driven. Na+-independent uptake at the apical 
membrane is most likely mediated by Oatp3. Probably transport proteins involved in 
basolateral efflux are Mrp1 and Oatp2. 
 
5.10 Comparison of TR, FL and FL-MTX Transport 
With these results we demonstrate the main differences between TR, FL and FL-MTX 
transport in CP: FL and FL-MTX transport mechanisms are equal in rat and shark CP, TR is 
transported by different transport proteins in rat and shark CP. Further differences between 
FL, FL-MTX and TR transport concern the proteins involved. 
As described above, FL-MTX is a concentrative, metabolism-driven two-step mechanism as 
well. Apical uptake was Na+-dependent and mediated most likely by Oat like protein (s), 
basolateral efflux was insensitive to PD and mediated by Mrp1 and Oatp2 in both rat and 
dogfish shark CP (Breen et al., 2004; Baehr et al., in press).  
TR efflux in dogfish shark CP is mediated by Mrp1 and Oatp2 as well, but apical uptake is 
Na+-independent and most probably mediated by Oatp3. In rat CP transport proteins involved 
in TR transport remain to be identified. A Mrp seems to be involved in basolateral efflux, 
uptake at the apical membrane of rat CP epithelium is mediated by Oat like, Na+-dependent 
protein(s). Outlining the results, FL-MTX and TR transport share some similarities, but in 
total they differ in rat as well as in shark CP. 
FL transport across CP epithelium is a concentrative two-step mechanism consisting of Na+-
dependent uptake at the apical membrane and PD-driven efflux at the basolateral membrane 
into blood. The herbicide 2,4-D had an inhibitory effect on FL transport across CP epithelium 
(Breen et al., 2002; Villalobos et al., 2002). As described above, FL uptake is mediated by 
Oat3. Different to FL efflux, TR efflux at the basolateral membrane was not PD driven in 
both rat and shark CP. Totally different transport proteins seem to be involved in FL and TR 
efflux. Like in rat CP, FL uptake at the apical membrane is Na+-dependent, but FL uptake is 
mediated by Oat3 and the proteins involved in TR uptake in rat CP are not identified by now. 
Different to FL uptake and TR uptake in rat CP, TR uptake in dogfish shark CP is Na+-
independent and mediated by Oatp3. Summarizing these findings, FL and TR transport are 
mediated by different transport proteins.  
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6 Summary 
Together with the blood-brain-barrier (BBB), the blood-cerebrospinal fluid (CSF)-barrier 
(BCSFB) formed by CP epithelium, plays an important role in protection of the brain and 
elimination of eventually toxic xenobiotics or metabolic waste out of the CNS. Due to the 
accretion of CNS diseases including brain cancer, HIV, schizophrenia, meningitis, depression 
and epilepsy, CP tissue gets more relevance as target for pharmacotherapy (Bachmayer et al., 
2005; Ghersi-Egea/Strazielle, 2001; Löscher/Potschka, 2005; Miller, 2004). To come to know 
more about CP function and elimination mechanisms we investigated into transport processes 
at the CP using different fluorescent compounds as model substances. 
Due to the tissue localization, small size and sensitivity of CP tissue in mammalians, we used 
different models to study mechanisms of organic anion transport before studies in rat CP were 
accomplished. Killifish proximal tubules are an excellent model for studying transport 
processes, because killifish can be obtained and held easily and proximal tubules isolation is 
facile. Killifish proximal tubules are stable at room temperature for a long period of time and 
fish analogs to the transport proteins expressed in mammalian kidneys are expressed in 
killifish proximal tubules. To a large extent transport proteins in kidney and CP are the same, 
as CP is also called the kidney of the brain (Spector/Johanson, 1991).  
We showed localization of the fish analog to Mrp4 to the luminal site of killifish proximal 
tubules and demonstrated transport of the fluorescent cAMP analog fluo-cAMP by Mrp2 and 
Mrp4 in killifish proximal tubules using confocal microscopy. Luminal efflux of fluo-cAMP 
in killifish proximal tubules was mediated by Mrp2 and Mrp4, transporters involved in 
basolateral uptake remain to be identified. Fluo-cAMP transport in killifish proximal tubules 
is, different to transport of FL-MTX transport mediated by Mrp2 (Notenboom et al., 2002), 
not regulated by the ET pathway or PKA. Further analyses are needed to assess regulation of 
fluo-cAMP transport in killifish proximal tubules. 
As shown for killifish proximal tubules, we demonstrated MRP2 and MRP4 mediated fluo-
cAMP transport in MDCKII-MRP2 and Sf9-MRP4 membrane vesicles. Membrane vesicles 
of transfected cells are used as model for transport processes due to the possibility to regard 
specific transport processes mediated by one protein. By the use of membrane vesicle studies 
we got evidences for specific, ATP-dependent fluo-cAMP transport by MRP2 and MRP4 
with fluo-cAMP as high affinity substrate for both proteins. 
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To examine these findings in rat CP we used the fluorescent molecule fluo-cAMP and 
confocal microscopy. Fluo-cAMP was transported from aCSF through CP epithelial cells in a 
dose-dependent and saturable manner. High accumulation in vascular/perivascular spaces and 
the interior of blood vessels are signs for an active, concentrative two-step mechanism of 
fluo-cAMP transport. Fluo-cAMP uptake at the apical membrane of CP epithelial cells is 
mediated by one or more Na+-dependent, most probably Oat like, proteins. Basolateral efflux 
is mediated by a Mrp, presumably Mrp1. Different to the findings we got from experiments in 
killifish proximal tubules and membrane vesicles of MDCKII-MRP2 and Sf9-MRP4 cells, 
fluo-cAMP transport in rat CP was not mediated by Mrp4, even though we demonstrated 
Mrp4 localization parallel to Mrp1 to the basolateral membrane of CP epithelium. Regulatory 
cascades were researched in rat CP and led to the result, that fluo-cAMP transport is 
insensitive to activation of PKC or PKA by ET or MAPK pathway. 
Another model used for investigation of transport processes in mammalian CP, is the CP of 
dogfish sharks by reason of its larger size, better accessibility and longer stability at room 
temperature. Morphology and ultrastructure of rat and dogfish shark CP showed several 
similarities (Villalobos et al., 2002). FL-MTX and FL transport were analyzed in rat and 
shark CP and the results were similar transport proteins involved in transport of FL and FL-
MTX, respectively, in rat and shark CP. Transport proteins mediating transport of FL and FL-
MTX were different, but similar for each organic anion in both species (Baehr et al., in press; 
Breen et al., 2002; Breen et al., 2004; Villalobos et al., 2002). To investigate into TR transport 
in CP, we used rat and dogfish shark CP and obtained interesting results. Transport proteins 
involved in TR transport in rat and shark CP were different. In rat CP TR transport was 
composed of Na+-dependent uptake at the apical membrane and basolateral efflux mediated 
by a Mrp, but not Mrp1, Mrp2 or Mrp4. In dogfish shark CP the findings were different: 
apical uptake of TR was Na+-independent and mediated by Oatp3. Efflux at the basolateral 
membrane of dogfish shark CP was mediated by Mrp1 and Oatp2.  
Further differences between both species were found investigating regulation of FL-MTX 
transport. FL-MTX transport was activated by PKA activation and inhibited by PKC 
activation in dogfish shark CP. Different to these findings PKA activation led to increased 
efflux of FL-MTX in rat CP, but PKC activation did not effect transport of FL-MTX in rat 
CP. 
Summarizing, we could demonstrate different transport mechanisms for transport of organic 
anions in different models. The small sized molecule FL, the medium sized dye TR and the 
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larger sized substances fluo-cAMP and FL-MTX seem to be transported by different transport 
proteins, but molecular weight seems not to be the crucial factor for the different mediations.  
Fluo-cAMP transport is different to transport of the nonfluorescent compound cAMP which is 
transported by Mrp4 (Van Aubel et al., 2002), and different to transport of its substituent FL. 
Despite the homology of CP and kidney proximal tubules, transport of fluo-cAMP is 
mediated by different transport proteins in rat CP and killifish proximal tubules, suggesting 
that killifish proximal tubules cannot be used as a model for transport processes in rat CP.  
Different from transport proteins involved in FL and FL-MTX transport, respectively, 
transport proteins mediating transport of TR seem to be different in rat and dogfish shark CP. 
The same was found for regulation of FL-MTX transport in rat and shark CP, even though 
transport proteins involved in transport of FL-MTX are the same in rat and shark CP, 
regulatory processes behind those proteins are different. We sum up, that defiant of the 
similar morphology and ultrastructure to rat CP, dogfish shark CP allows only limited 
predictions with respect to transport proteins in mammalian CP. 
Confocal microscopy is a distinguished tool for functional analyses because uptake step, 
transport through the cells and efflux can be visualized. Due to the use of different models we 
could draw conclusion about characteristics of organic anion transport and transport proteins 
involved. In CP tissue several proteins are detected on RNA level, but protein localization 
remains to be studied to get a clearer view of transport processes at the BCSFB. First insights 
into regulatory processes involved in transport processes could be taken, but further 
experiments are needed to be done to understand regulation of transport processes for organic 
anions. 
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7 Outlook 
 
The blood-CSF-barrier is an important barrier which protects the brain and actively regulates 
homeostasis of the liquor. Most water soluble substances can only be transported actively 
through the epithelium. For the therapy of brain diseases, especially HIV, it is very important 
to get a better knowledge about transport proteins involved in transport across CP epithelium. 
In the presented study we used fluorescent molecules and confocal laserscanning microscopy 
to visualize transport processes across CP epithelium. The advantage of this technique is the 
facility of watching both steps of transport across the epithelium: uptake at the apical 
membrane and efflux into blood at the basolateral site. We demonstrated transport processes 
for the fluorescent molecules fluo-cAMP and TR and compared it with results previously 
found for FL and FL-MTX (Baehr et al., in press; Breen et al., 2002; Breen et al., 2004; 
Villalobos et al., 2002). We could interprete the transport mechanisms and found transport 
proteins involved either in apical uptake or in basolateral efflux. Some transporters involved 
in transport of the fluorescent dyes are not identified by now. Choudhuri et al. (2003) 
described expression of other Mrps, Oats and Oatps on RNA level in rat CP epithelium, but 
protein expression is not revealed by now.  
In further studies we will prove expression of transport proteins on protein level and 
localization in CP epithelium. We will analyze expression of breast cancer resistance protein 
using RT-PCR and indirect immunostaining and start transport studies using the Bcrp 
substrate mitoxantrone. 
Furthermore, we want to accomplish more specific transport studies in membrane vesicles 
from transfected cells to verify fluo-cAMP transport mediated by MRP1. We produce 
MDCKII-MRP1 cell membrane vesicles and carry out western blot studies to reveal protein 
expression in thoses vesicles. Uptake studies using fluo-cAMP as substrate will be performed 
next. 
Another interesting field is the regulation of transport processes in CP. Not much is known 
about regulatory processes in CP epithelium. We found that PKA is involved in regulation of 
FL-MTX transport in rat CP and PKA as well as PKC are involved in regulation of FL-MTX 
transport in dogfish shark CP. The other tested pathways were not involved in regulatory 
processes involved in transport of fluo-cAMP, TR or FL-MTX. Further studies will 
investigate regulation of fluo-cAMP transport in rat CP and killifish proximal tubules and the 
hormones and cascades involved. Xiang et al. (2005) analyzed expression and localization of 
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P2X receptors in rat CP and assume involvement of P2X receptors in secretion of CSF. These 
receptors may play a role in regulation of transport processes in rat CP as well. 
All in all, not much is known about transport processes in CP, proteins involved and 
regulation. Protein localization of several transport proteins as well as their involvement in 
transport processes at the BCSFB and regulation of these transport processes remain to be 
analyzed.  
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